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INTRODUCTION
Inlatenineteenth-century Britain seriousattemptsweremadetopromotescience, to
providebettereducational facilitiesforscientists, and toincrease theapplication ofthe
sciencesinindustryandcommerce.TheseincludedtheGreatExhibitionof1851,withits
emphatic display ofscientific achievements; the internal reorganization ofthe Royal
Society and its administration of a government grant to support research; the
indefatigable efforts of T. H. Huxley and his associates to publicize science and its
possibilities; andthe increasing number ofexpressions ofconcern about theeconomic
advantages gained by industrial competitors, particularly in Germany, which
enthusiastically embracedandfurthered scientificmethods.1 However, therewerealso
appreciable reservations about these new approaches; and in the medical world in
particular, considerable ambivalence was expressed towards science and its
practitioners.Therewas,forexample,readyacceptancethatclaimstoscientificexpertise
couldconferadditionalstatusonmedicalpractitionersandenhancethereputationofthe
medical profession. Nevertheless, there was also distrust, and even distaste, for an
endeavour that was seen to belong more to the artisan class than to the gentlemanly
professionthatmedicinehadbecome.2Thepharmaceuticalsciences,suchastheywereat
this time, were especially subject to these contrary pressures. Within the developing
pharmaceutical industry itself, a small but growing number ofagitators compared the
lack ofscientific support in Britain with the strong encouragement lent to research in
some American and European countries, by governments and the manufacturers
themselves. At the same time, however, many medical men felt threatened by new
scientificdevelopmentsthattheysawasencroachingupontheirtraditionalskills;whilst
others were openly disdainful of such tradesmen as chemists and druggists claiming
scientific ambitions that properly belonged to the medical profession.
* E. M. Tansey, B.Sc., PhD., Wellcome Institute for the History ofMedicine, 183 Euston Road, London
NW1 2BP.
I Two useful summaries of these debates are provided by R. M. MacLeod 'The resources ofscience in
Victorian England: the endowment of science movement, 1868-1900' in P. Mathias, (editor), Science and
society, 1600-1900, Cambridge University Press, 1972, pp. 111-66; and P. Alter, The reluctant patron:
science and the state in Britain 1850-1920, Oxford, Berg, 1987, passim, especially pp. 13-74.
2 The medical practitioners' struggle for professional status is described by M. J. Peterson, The medical
profession in mid-Victorian London, Berkeley, University of California Press, 1978, passim.
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An additional, but hitherto unrecognized, problem was the constraint put upon
medical research by the 1876 Cruelty to Animals Act, which regulated the use ofliving
animals in experimental work. The Act had, from its very beginnings, aroused much
hostility and resentment among the medical profession because ofits restrictions and
impositions.3 One requirement oftheAct wasthatall premises whereexperiments were
performed on animals had to be registered with the Home Office. Until 1901, these
were either laboratories associated with hospitals, medical schools, or medical
corporations, or, very occasionally, the private laboratories ofmedical men. The first
pharmaceutical manufacturer to apply for the registration of laboratories owned by
him was Henry Wellcome, proprietor ofBurroughs Wellcome and Co. His submission
aroused several debates about the application ofthe existing law to new experimental
methods, the desirability of drug standardization and physiological testing, and the
propriety of allowing a "commercial" manufacturer the same privileges, even for his
private laboratories, accorded to medical organizations. Thus, Wellcome's application
provides a focus for the study ofsome ofthe ambivalent attitudes towards science, and
for an analysis ofthe effect ofthe 1876 Cruelty to Animals Act on the development of
pharmaceutical research in Britain.4
BURROUGHS WELLCOME AND CO.
The pharmaceutical firm Burroughs Wellcome and Co. was established in Britain in
1880 bytwo American pharmacists, Silas M. Burroughs and HenryS. Wellcome.5 One
of their initial aims was to introduce into European markets the type of compressed
medicine succeeding in America, and in 1884 Wellcome registered the trademark
"Tabloid" to describe some of these preparations. Burroughs's death, in 1895, left
Wellcome as the sole proprietor of the Company, and his financial security enabled
him to indulge extensively such interests as archaeology and anthropology.6 It also
3 R. D. French, Anti-vivisection and medical science in Victorian society, Princeton University Press,
1975, pp. 112-58. The comparable restrictions imposed by English patent law are discussed by H. J.
Habbakuk, American and British technology in the nineteenth century: the searchfor labour-saving inventions,
Cambridge University Press, 1962, p. 216. See also L. H. Haber, The chemical industry during the nineteenth
century: a study of the economic aspect of applied chemistry in Europe and North America, Oxford,
Clarendon Press, 1958, especially 'Chemical manufacturers and their problems', pp. 186-230.
4Muchmaterial usedinthisstudyisfrom the ArchivesoftheWellcome Foundation (WF)quoted with the
permission of the Wellcome Foundation Ltd., and from the Archives of the Wellcome Institute (WI),
quoted, as are other WI documents, with the permission ofthe Trustees of the Wellcome Trust. I thank the
WF Archivists Mrs R. C. E. Milligan and Mrs M. F. Williamson for their help.
5 Histories of Burroughs Wellcome and Co. (BW&Co) and biographies of its founders are few and
incomplete: C. M. Wenyon, 'Sir Henry Solomon Wellcome', Obit. Not. FRS Lond. 1938, 2: 229-38; Sir
Henry Wellcome, a biographical memoir, London, The Wellcome Foundation, 1953; G. MacDonald,
In pursuit of excellence, London, The Wellcome Foundation, 1980; H. Turner, Henry
Wellcome, the man, his collections and his legacy, London, Heinemann Educational Books and the
Wellcome Trust, 1980; A. W. Haggis, 'The Life and work of Sir Henry Wellcome', WI typescript, 1942;
R. C. E. Milligan, 'Henry Solomon Wellcome' in D. J. Jeremy, (editor), Dictionary ofbusiness biography,
London, Butterworth, 1986, vol. 5, pp. 727-36. Details of Burroughs are included in MacDonald (above),
pp. 19-21, and in obituaries, e.g., Chem. & Drug., 1895, 46: 213-14; ibid., 254-8; Pharm. Era, 1895, 13:
210-11, 720-2. See also A. R. Hall and B. A. Bembridge, Physic and philanthropy: the Wellcome Trust
1936-1986, Cambridge University Press and The Wellcome Trust, 1986.
6Tumer, op. cit., note 5 above, pp. 37-76; Hall and Bembridge, op. cit., note 5 above, pp. -1 8, 121-49;
G. M. Skinner, 'Sir Henry Wellcome and his museum for the science of history', Med. Hist., 1986, 30:
383-418; G. Russell, 'The Wellcome Historical Museum's dispersal of the non-medical material,
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allowed him to establish, in addition to the research facilities within his factories, what
he considered to be his private laboratories, the Wellcome Chemical (1896), Tropical
(1902) and Entomological (1920) Research Laboratories.7 However, the first such
scientificventure wasalaboratory, opened in 1894fortheproduction ofthethen novel
therapeutic agent of diphtheria antitoxin, which ultimately became known as the
Wellcome Physiological Research Laboratories (WPRL).8 Although in later years it
was claimed that the establishment of the WPRL was independent of both the
commercial company and ofSilas Burroughs, such assertions must be questioned. In
1894 the partnership between Burroughs and Wellcome still existed, although
negotiations were under way to terminate it.9 It seems likely that Burroughs knew and
at least tacitly approved of the establishment of the WPRL, as all major company
decisions had to be ratified by both partners, but there is, as yet, no direct or
circumstantial evidence of his involvement.10 Even more questionable is the
independence of the laboratories from the commercial company. They were first
administered directly from the Company headquarters in Snow Hill, their staff
members were employees of the Company and, indeed, the main product of the
laboratory, diphtheria antitoxin, was advertised and sold by the company.
THE ESTABLISHMENT OF THE WPRL AND THE EARLY PRODUCTION OF DIPHTHERIA ANTITOXIN
In 1890, Behring and Kitasato first raised diptheria antitoxin in sheep and goats, and
four years later Roux further refined the technique by raising the serum in horses.
These advances stimulated many institutes and companies to attempt large-scale
production of therapeutic serum.'1 In Britain, Burroughs Wellcome and Co. was
among the first to announce its success.12 In 1894, two weeks after the British Medical
1936-1983', Museums J., 1986, 86(Suppl.): S3-S29; H. J. M. Symons, 'The development of the Wellcome
Collections', Mus. Ethnograph. Gp Newsletter, 1987, 20: 1-20.
7 Turner, op. cit., note 5 above, pp. 17-26; R. C. E. Milligan and E. M. Tansey, 'The early Wellcome
Research Laboratories, 1894-1914', presented to the symposium on the History of the Pharmaceutical
Industry, Wellcome Institute, January 1987. The 1890s saw the rise of "research within the firm", BW&Co
being among the first in Britain in this respect: M. Sanderson, The universities and British industry,
1850-1970, London, Routledge & Kegan Paul, 1972, p. 20.
8 Turner (op. cit., note 5 above, pp. 17-8) invariably called them the Wellcome Physiological Research
Laboratories, but in internal correspondence this name was first used in January 1897. The founding of the
Wellcome Chemical Research Laboratories (WCRL) in 1896, after Burroughs's death, may have influenced
the naming of the Physiological Laboratories.
9 Turner, op. cit., note 5 above, pp. 11-12.
10 Thelaboratoriesarenotmentionedinsurvivingcorrespondence betweenWellcomeandBurroughs, viz.,
WF:HSW Private Letter Books 1881-1897, S/G/148/2; WF:D2 DW Business Correspondence 1887-1895;
WF:C5 HSW Personal 3 1890-1896; WF:B3 HSW Letter/Memoranda Book 1893; WF:B3 HSW
Letter/Memoranda Book Aug 1893-March 1898. F. G. Hopkins told H. H. Dale (in 1941) that Burroughs
had never mentioned research to him, (and also provided the intriguing information that Wellcome had
approached him before 1898 about "going to do research for the firm"). WF/180: Registration of the
Wellcome Physiological Laboratories (henceforth WF/180:WPRL).
"E. von Behring and S. Kitasato, 'Ueber das Zustandekommen der Diphtherie-lmmunitat und der
Tetanus-Immunitat bei Thieren', Dtsch. Med. Wochen. 1890, 16: 1113-14. P. R. E Roux and A. L. F. J.
Martin, 'Contribution a l'etude de la diphtherie (serum therapie)', Ann. Inst. Pasteur, 1894, 8: 609-39. The
British saw this as a further example ofthe "made in Germany" problem e.g., Chem. & Drug., 1896, 48:46.
See also note 160 below.
12 Others were the British Institute ofPreventive Medicine (BIPM) and Dr Emmanuel Klein ofthe Brown
Institute: 'Supply ofdiphtheria antitoxin in England', Br. med. J., 1894, ii: 1063. 'The antitoxin treatment
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Journalreported thattheantitoxincouldnotbeobtained in London, itwasannounced
that "Messrs. Burroughs, Wellcome and Co. have arranged to supply diphtheria anti-
toxin. Theyhave beenpreparingquietly forsomemonths back (it takes thattime before
the horses become immune), and hope to have serum for distribution next week."13
This first supply was exhausted within hours, but the Company advised that
production would continue, and it apparently provided serum at a price below
production costs.14 It was prepared, according to the label, "under the personal
superintendence of an experienced London bacteriologist" and issued from its
commercial headquarters to selected pharmacists.15 This new therapy attracted much
attention and controversy, both at the time of its introduction and for many years
afterwards, but a detailed discussion is beyond the scope of the present paper.16
In April 1895, T. J. Bokenham of St Bartholomew's Hospital17 was formally
appointed to raise, test and issue diphtheria antitoxin on behalf of the Company,
although he had been associated with it for several months already.18 From this time,
theworkwas doneat 10 Devonshire Street, Portland Place, previouslyunknown as an
address for the Wellcome Laboratories.19 Serum production continued under the
of diphtheria: the supply of serum', ibid., p. 1452, mentions BW&Co's use of Roux's method;
advertisements for BW&Co's antitoxins in the Lancet, 5 Jan. 1895 and the Br. med. J., 12 Jan. 1895,
stressed production "at our own laboratories". The first advertisements for the BIPM antitoxin appeared
in the Lancet, 12 Jan. 1895.
3 Chem. & Drug. 1894, 45: 736.
14 Ibid., p. 857; Haggis, op. cit., note 5 above, p. 272. At the 1895 British Medical Association (BMA)
Exhibition, BW&Co, whopromoted their "laboratory mostcompletely equipped and under thecharge ofa
well-known physiologist and bacteriologist" (Br. med. J, 1895, ii: 295-5), were warmly congratulated on
sup1plying serum: Chem. & Drug. 1895, 47: 235-6.
Chem. &Drug. 1895,46:28. BW&Cocontinued toproduceandadvertiseotherdiphtheriaremedies,e.g.
magnesium sulphate: ibid., 47: 525.
6 E.g., 'De re nova', Chem. & Drug. 1894, 45: 46; 'The anti-toxin treatment ofdiphtheria', ibid., 644 5;
'What is antitoxin?', ibid., 46: 16-17; 'New medication', ibid., 47: 929-30; 'The anti-toxin treatment of
diphtheria', Br. med. J. 1895, i: 42-5. A useful survey is H. J. Parish, A history ofimmunization, Edinburgh,
E. & S. Livingstone, 1965, pp. 118-31; an American context is provided by J. M. Liebenau, 'Public health
and the production and use ofdiphtheria anti-toxin in Philadelphia', Bull. Hist. Med., 1987, 61: 216-36.
17 ThomasJessopBokenham: see,e.g., MedicalDirectory, 1892,p.99.AnearlyreportofBW&Co'sserum
production noted that he "has distinguished himselfin this branch ofmedicine", Chem. & Drug., 1895, 46:
870.
18 Bokenham's employment began 29 April 1895, according to WF:P2 Staff Records Book 1879-1902,
p. 35; a date repeated in WF:K 'Notes on early diphtheria serum, a typescript history ofthe WPRL', n.d.,
c. 1927. WF:P7 gives 16 September 1894 as his starting date, although a notecautions "We have no official
records of the early history of the Laboratories. All dates except very recent ones are subject to
confirmation." BW&Co paid for A. Chopping, employed "in Dr. B's labtY" from 26 January 1895 (WF:P2
Staff Record Book 1879-1902, p. 31); and there is correspondence between Bokenham and BW&Co on
serum-therapy prior to 29 April 1895 (WF:HSW Letter Books 1881-1897, S/G/148/2, pp. 673, 682).
Perhaps he was paid a retainer from the earlier, and formally employed from the later, date. In only one
Medical Directory entry did he mention BW&Co (1897, p. 110). See also note 128 below.
19 MacDonald, op. cit., note 5 above, p. 82; Turner, op. cit., note 5 above, p. 18; and 'Foundation ofthe
Wellcome Physiological Research Laboratories', extracted from 'History of the Firm File' WF:K "from
information from Dr. Dale": all give 1894 as their starting date in Charlotte Street with stables in Lisson
Grove. According to Sir Henry Wellcome, op. cit., note 5 above, the Physiological Laboratories were
founded in 1894 "in London"; C. H. Kellaway, 'The Wellcome Research Institution', Proc. R. Soc. Lond.
B, 1948, 135: 259-70 would have the laboratories start "in London" in 1895. Haggis, op. cit., note 5 above,
p. 272, established them in an extension to Snow Hill headquarters ofBW&Co, moving to Charlotte Street
and Lisson Grove in 1896, as also claimed by H. J. Parish, 'The Wellcome Research Laboratories and
immunization: a historical survey and personal memoir', typescript WF/34(n.d.). Documents in WF/
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auspices ofBurroughs Wellcome and Co., which encouraged the raising ofantitoxins
against other diseases.20 By 1896, the rapid development of, and associated demand
for, sero-therapy led to a move from Portland Place to larger facilities at 40 Charlotte
Street. Bythistime, itwasbecomingobvioustoWellcomethatanimalexperimentation
wasrequirednotonlyto test,quantifyandstandardizediphtheriaantitoxin, butalsoto
develop and expand the chemo-therapeutic work of the company by promoting
vigorous physiological testing of animal-derived and chemically-manufactured
pharmaceutical preparations. At the same time, the work of the laboratories was
brought totheattention oftheHomeOfficeand inMay 1896itadvisedWellcomethat
application should be made to register the premises, in accordance with the 1876
Cruelty to Animals Act, for the purposes of testing antitoxins.21
THE CRUELTY TO ANIMALS ACT, 187622
The proposal, and subsequent passing, ofthe Cruelty to Animals Act (39 & 40 Vict.,
c. 77)stimulatedgreatdebatebothinandoutsideParliament.23 TheAct,whichapplied
to experiments calculated to give pain, required every researcher to hold a personal
licence, granted on the recommendation of two eminent medical or scientific
authorities. Such licences were available for use only at specified premises registered
with the Home Office; and certain classes of experiments required the additional
sanction of Certificates (described below), also granted on the personal
recommendation of eminent persons.24 The Act did state that "private places, in
addition to public laboratories, could be occasionally made legally available for
purposes ofresearch experiment", but required a licensee to "perform hisexperiments
ataplace registered bythe Home Secretary and subject to inspection at any time". The
180:WPRL show the laboratories at 40 Charlotte Street in autumn 1896; prior to this they were at 10
Devonshire Street, Bokenham's address in the Medical Directory from 1895 until 1898.
20 BW&Co toBokenham, 8April 1895, mentions antitoxins forconsumption; BW&Co to Bokenham, 29
April 1895, refers to serum therapy for erysipelas, puerperal fever, etc. "we would like you to proceed with
your investigation ofthis with all urgency. We think it very important that we should be in the forefront
with this". Wellcome to Bokenham, 15 May 1895, discussed increasing large animal immunity. All in
WF:HSW Letter Books 1881-1895, S/G/148/2 pp. 673, 682, 689. Chem. & Drug., 1896, 48: 825 reported a
French anti-choleraic serum; the copy in the Wellcome Institute (originally from BW&Co) has the
marginal mark in Wellcome's writing "notify Bokenham". Anti-streptococcus serum was "prepared by
myself, and supplied to the profession through the firm of Burroughs, Wellcome and Co.": T. J.
Bokenham, 'Additional notes on the preparation ofanti-streptococcus serum', Br. med. J., 1896, ii: 3-4.
21 The Secretary ofState for the Home Office (HO) learned ofthe serum work from The Wellcome 1896
Diary and invited BW&Co to apply forregistration, licences, and certificates. Bokenham promptly did this
on Wellcome's behalf. HO to BW&Co, 4 May 1896; Wellcome to HO, 17 July [1896] both in the Public
Record Office [henceforth PRO] HO 45/11092/B21744/1. I thank the Home Office for permission to
examine and quote its records, and the Departmental Record Officer for assistance.
22 Acontemporary summary is S. Paget, 'The Act relating toexperiments onanimals', in Experiments on
Animals, London, T. Fisher Unwin, 1900, pp. 213-69. The correct terminology, that places were
"registered" and people were "licensed", has been employed throughout this paper; contemporary usage
often confused the two and direct quotes retain the original words. Confusion also arose over definitions of
"experiment", "cruelty", and "pain": see R. S. Vine, 'The history of the Research Defence Society',
Conquest, 1987, 176: 1-16. Likewise, the Cruelty to Animals Act was often incorrectly referred to as the
"Anti-Vivisection" or "Vivisection" Act.
23 See French, op. cit., note 3 above.
24These weremedicalprofessors, andthePresidents oftheRoyal Societies ofLondon andEdinburgh and
the Royal Colleges.
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Inspectors were themselves medical men. G. D. Thane, for example, who was closely
involved with Wellcome's application, was Professor of Anatomy at University
College London.25 Although in the early years ofthe Act such "private places" as the
"cellar at 13 Claremont, Bradford" (1886) were registered, by the 1890s most
experiments were performed in university or hospital laboratories.26
There were two questions relevant to the antitoxin work of the Wellcome
laboratories: did the raising ofdiphtheria antitoxin itselfrequire a licence (and hence
have to be performed on registered premises)?; and did the testing and quantification
ofthe antitoxins require a licence? Such problems had concerned the Home Office for
many years. As early as December 1879, similar questions were referred to the Law
Officers ofthe Crown for Opinion, and theywere raisedagain in 1894, 1895, and 1896.
The variety of views expressed indicate considerable confusion.27
The 1879 Opinion was that the initial inoculation to raise antitoxins did not appear
to beanexperiment under the Act, but that ifaCertificate wasrequired forthework, it
wouldhave to beCertificate A, i.e. forexperimentationwithout anaesthetics. The Law
Officers cautioned that, in the public mind, Certificate A was associated with painful,
rather than relatively painfree, experiments; and, (just three years after the passing of
the Act), that the language ofthe Statute was ill-defined. The 1894 Opinion was that
raisingantitoxinswasnotanexperimentasitwasnotfortheascertainingofascientific
truth, but that some pain might occur if, for example, excessive quantities of blood
were drawn. The same Law Officers offered a substantially different Opinion the
following year when the question was again referred to them: "inoculations for the
purpose of testing the efficacy of a substance known to be a cure for disease and
produced for the purpose ofbeing used in particular cases, is [sic] not an experiment
within themeaningofthe Act." They therefore declared thatinoculations made forthe
diagnosis orcure ofdisease were outside the 1876 Act. However, they maintained that
similarwork performed forscientificcuriosity alone was anexperiment, and suggested
thattheproblemcould beresolvedbyobtainingabindinglegaldecision in court. A few
months later, different Law Officers offered a different Opinion: the raising of
25 French, op. cit., note 3 above, pp. 143-4. The appointment of medical men as Inspectors was not
uncontroversial, e.g., "one wonders whether an Inspector in such a position might possibly again, even
unwittingly have overlooked some small infringement of the act in the interests ofhis own profession":
J. Pellow, The Home Office 1848-1914, from clerks to bureaucrats, London, Heinemann Educational
Books, 1982, p. 198.
26That the College ofState Medicine had been registered was important when, in 1893, itamalgamated
with the newly created BIPM (later the Jenner, and Lister, Institute): The Lister Institute of Preventive
Medicine, 1891-1966, London, The Lister Institute, 1966, p. 10. The Conjoint Laboratories of the Royal
Colleges ofSurgeons ofEngland and Physicians ofLondon were registered within six months ofapplying
in 1890; Minutes ofCouncil, Royal College ofSurgeons, 1889-1891, pp. 172, 270-1. The College records
are quoted with the permission ofthe President and Council of the Royal College ofSurgeons of England
(henceforth RCS). See also Z. Cope 'The Examination Hall on the Embankment and the Research
Laboratories' in The Royal College ofSurgeons: a history, London, Anthony Blond, 1958, pp. 165-70; and
A. M. Cooke, 'The Laboratory and Museum', in A history of the Royal College of Physicians, Oxford,
Clarendon Press, 1970, vol. 3, pp. 920-30. Other applications for "private" registrations were refused at
this period, e.g. HO to Seligman, 1 Mar. 1900. PRO H0156/13 p. 113.
2 LegalOpinionswereproducedon 3 Dec. 1879, byJohn Holker andHardingeGifford; 7July 1894 and 2
July 1895, by R. T. Reid and Frank Lockwood; and 29 Jan. 1896, by R. E. Webster and R. B. Finlay. All
documents in PRO H045/11092/B21744/1. The letter from the HO to BW&Co, op. cit., note 21 above,
referred to the Opinion of January 1896.
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antitoxins in horses or asses was not an experiment because it was done to produce a
particular, specified substance and not for scientific enlightenment; but testing
procedures on small rodents were experiments for medical purposes and therefore
within the Act, as the Act did not specify that it applied only to work for the
advancementofknowledge. Afurtherquestion astowhethersuchworkwascalculated
to givepainevoked the response that the Act was hardly designed to cover such minor
discomfort as that endured by achild with measles, but that a legal decision, obtained
by a prosecution, might clarify the situation.
Thus, by the time ofWellcome's application in mid-1896, Home Office directives
were that the use ofan animal for a procedure ofwhich the outcome was known and
whichwas notcalculated tocause pain, i.e. theraising ofdiphtheria antitoxin, was not
an experiment and therefore did not come under the 1876 Act. However, the
experimental use of animals for raising new antitoxins and for all testing and
standardizationproceduresdidcomeundertheAct. Forsuchworkthepremiseshadto
be registered, and the researchers needed valid Home Office licences and, when
necessary, the appropriate Certificates allowing particular experiments to be
performed on specified animals.28 Consequently, Bokenham could raise diphtheria
antitoxin on unregistered premises, but the resultant serum had to be tested in Home
Office registered laboratories, under the authority of the appropriate licence and
Certificates.
Bokenham had held a Home Office licence, with several A and B Certificates, since
1888, and throughout his association with Burroughs Wellcome and Co. this was
available at both the Conjoint Laboratories of the Royal Colleges of Surgeons and
Physicians and at St Bartholomew's Hospital.29 Since he made no experiments at the
Conjoint Laboratories during this time, the returns he made (43 experiments under
Certificate A in 1894; 36 experiments in 1895 ofwhich 34 were under Certificate A;
nonein 1896; and 18 underCertificate Ain 1897)presumably refer to work performed
at St Bartholomew's Hospital.30
Thus,withoutevenconsideringthe"commercial" problems, thescientificcontext of
Wellcome's 1896 application was recognized to be important but troublesome. An
28 To summarize Certificate conditions briefly: licence-only experiments were non-recovery experiments
performed completely under anaesthesia. Certificate A permitted work without anaesthetics: principally
simple inoculations, venesection, and feeding experiments. Certificate B covered experiments in which
anaesthesia was used for only part of the procedure, i.e. for recovery surgery, with additional stringent
regulations about aseptic surgical procedures and the after-care ofwounds. Certificate C was required for
demonstrations to approved professional audiences; Certificate D (which rapidly fell into disuse) was
required for the demonstration of facts already known. Certificate E, in conjunction with an A or B
Certificate, was needed for research on cats or dogs: in 1893 it was divided, E to accompany A and EE to
accompany B, for work on these domestic animals. Finally, Certificate F, again in conjunction with
Certificate A or B, was needed for experiments on horses, asses, or mules.
29 Home Office AnnualReturns ofExperiments [HO Returns] 1889-1900, London, HMSO. Bokenham's
applications for A Certificates (toinoculate rodents with microbes or drugs) are documented in the Minute
Book of the Association for the Advancement of Medicine by Research, 20 July 1882-18 June 1891. WI
MS 5311, ff. 18, 21, 71, 76.
30 MinutesofCouncil, RCS, 1893-1895; 1895-1897; 1897-1899. Bokenhamworkedtherebeforeandafter
his Wellcome employment (Minutes ofCouncil, 1891-1893, 1893-1895, 1897-1899), on 'Immunity against
Tubercule, Erysipelas and Scarlatina'; 'Clinical Uses of Erysipelas Toxines etc', 'Chemistry of Enteric
Fever', and 'Physiological Properties of Bacterial Toxins'. See also HO Returns, 1894-1897.
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internal Home Office memo in July of that year, detailing all the previous Opinions,
made it clear that
Thequestion raisedinthepresentcaseisnotwhetheraLicenseshould begrantedfor
testingexperiments, butwhetheraprivatelaboratory should be registered. I do notsee
anything in the action taken recently by the H.O. which in any way prevents this
question being considered entirely on its merits. No doubt the attention of Messrs.
Burroughs and Wellcome was called to the principles on which the H.O. in the future
proposed to act, but I see nothing in that letter [B10121/15] which pledges the H.O. to
register a private Laboratory. The testing experiments might well be carried on at a
place already licensed.
The question however ofregistering private Laboratories for this purpose is a very
important one, and the Conditions under which if at all such registration should be
allowed require very careful consideration. I think in the first place it would, before
arriving at any conclusion, be well to discuss the matter with Dr. Poore [the Home
Office Inspector]. Afterwards it may well be that the S. of S. [Secretary ofState] will
wish to have advice from other medical and scientific authorities.3'
Almost immediately Dr Poore32 visited the new Wellcome premises at 40 Charlotte
Street and reported,
They are excellent ... now being fitted, as perfectly as possible, for Bacteriological
work by Messrs. Burroughs &Wellcome. But it is a Private Laboratory and by placing
it on the Register the Home Office will be departing from its usual custom as to private
houses. If the use of antitoxins of various kinds should increase as seems not
improbable it may well be that every manufacturing chemist in the Country will want
facilities equal to those accorded to Messrs. B&W.... I therefore recommend that No.
40Charlotte Street be Registered but before this recommendation is carried out I hope
the whole question will be carefully reconsidered ....
In a different hand, at the bottom of Poore's report, the public advantages of such
work are contrasted with the difficulties of creating a precedent in registering
"commercial" premises. After Poore confirmed that the application could be refused
without undue hardship to the Company, a letter was sent to Bokenham, informing
him that testing operations must be performed on other registered premises.33
The whole issue ofraising antitoxins under the 1876 Act was addressed specifically
by the Home Office Inspector in his Annual Report for that year (1896), although he
did not mention Wellcome's application. A summary of the 1894-1896 Returns of
Experiments is given in table 1 and it shows a large increase in the total number of
experiments performed, in particular those under Certificate A, the principal type of
work to be done at the WPRL.
31 HO report, 20 July 1896, compiled by Kenelm Digby, Permanent Secretary at the HO (1895-1903),
addressed to Sir Matthew White Ridley, Secretary of State at the HO (1895-1900), PRO H045/11092/
B21744/1. A postscript cautions, "The licensing ofa private laboratory for commercial purposes as will be
seen is a totally new departure". The letter B10121/15 is that of4 May 1896, op.cit., note 21 above. Details
of the HO staff are taken from F. Newsam, The Home Office, London, George Allen & Unwin, 1955, p.
212; and D. A. Pickrill, Ministers of the Crown, London, Routledge & Kegan Paul, 1981, pp. 33-4.
32 French, op. cit., note 3 above, p. 170, claimed Poore was HO Inspector from 1900, but HO Returns show
him as Assistant Inspector to Professor Erichsen in April 1889, and full Inspector by 1890. He retired in
1899, thanked "for the delicate nature of the duties you have so ably performed". HO to Poore, 13 Feb.
1899. PRO HO156/12 p. 190.
33 Report of Poore, 23 July 1896, PRO H045/11092/B21744/1.
8The Wellcome Physiological Laboratories
TABLE 1: SUMMARY OF THE RETURNS OF EXPERIMENTS, 1894-1896
Experiments Certificate
Licensees34 Total35 under36 not under37 'A'
Total Active places anaesthetics experiments
1894 185 129 40 1565 1539 1507
1895 213 148 36 2317 2362 2317
1896 236 166 39 2203 5297 5217
The Inspector recognized that "The discovery of antitoxins has led to their
preparation on a large scale; but, as these remedies cannot be safely and effectually
used on human beings without being previously tested upon rodents, the preparation
ofantitoxins has necessitated a large number ofinoculations."38 This indicates quite
clearly Home Office sensitivity about the increase in animal experiments and its
concern to relate the work to therapeutic advances. It might be significant, therefore,
that during 1896, when Bokenham applied on behalf of the WPRL, there was no
increase in the total number of registered places.
RESPONSE TO THE HOME OFFICE REFUSAL OF REGISTRATION
The Home Office's refusal to register the Wellcome laboratories aroused an
immediate response from Bokenham ("Personally, I can only regret the illogical
position which the Secretary ofState has considered it necessary to adopt, and I hope
to be in a position to advance ere long further arguments which may induce him to
alter his decision"), who asked Dr Poore for precise details ofhow the Secretary had
arrived at his decision.39 Bokenham privately admitted to Wellcome that "In my
earliestdays ofcontact with the Home Office it wascarefully impressed upon me that
a policy of civility did not altogether pay with them, & that the best chance of
obtaining any concession from that Department was afforded by claiming as a right
what one wanted & NOT by asking for it as a privilege!"40
He consulted further with Dr Poore and Professors Victor Horsley and Charles
Roy as to the best way ofresolving the situation. Horsley, Professor ofPathology at
University College London, had already attracted attention from the anti-
vivisectionist movement whilst Professor-Superintendent of the Brown Institute
(1884-90).41 Charles Smart Roy had been a similar target when he was at the Brown
34"Active licensees" performed experiments during the previous year, and do not include those who
held licences but performed no experiments.
35 The registered places used by active licensees, often including several "places" within one building.
36 Experiments under anaesthesia for all or part of the time, i.e. returns under licence only, or under
Certificates B, B and E, B and F, or C.
37 Experimentswithoutanaesthetics(principallyinoculations,venesections,etc.)i.e. underCertificatesA,
A and E, A and F.
38 HO Returns for 1896.
39 Bokenham to HO, 15 Aug. 1896; Bokenham to Poore, 21 Aug. 1896. Both in PRO H045/11092/
B21744/2.
40 Bokenham to BW&Co, 16 Aug. 1896. WF/180:WPRL.
41 See S. Paget, Sir Victor Horsley: a study of his life and work, London, Constable & Co., 1919;
J. B. Lyons, Citizen surgeon, London, Peter Dawney, 1966, particularly chapter 13, 'Experiments on
animals', pp. 130-50.
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Institute, and had been advised bytheAssociation fortheAdvancement ofMedicine by
Research to buy dog licences for his experimental animals, in an attempt to placate
anti-vivisectionist hostility.42 Bokenham reported that Horsley was particularly
sympathetic and "almost the only man whom the Home Office fear ... I do not think
any more powerful ally could be wanted; he will give me all the assistance in his power,
and he thoroughly understands how to tackle the Authorities", adding later, "I did not
take a single step or make any communication to the Home Office or to Dr Poore,
without in each instance having discussed the matter fully with Prof. Horsley &
submitted all written communications to him for & received criticism."43
How far Wellcome was convinced by these assertions is uncertain, as a note on the
bottom of Bokenham's letter cautions "Mr. Sm." (J. C. Smith, a senior employee of
Burroughs, Wellcome who frequently dealtwith the laboratories on Wellcome's behalf)
"on all points consult with Mr. C.F." (Chune Fletcher, a close friend ofand medical
adviser to Wellcome, particularly on matters of medical etiquette).44
Although Bokenham appeared confident that he was not infringing the existing
regulations because the inoculations did not cause the animals pain, it is not at all clear
where his experiments were conducted. One week later, he appeared less sure of his
position. "I have secured so much professional sympathy that I have little doubt as to
ultimatelytriumphing: butin themeantime I amleftnoalternative-asfarasthetesting
operations areconcerned-buttoentirelyignorethebearingsoftheActuponthem. This
the Home Office well knows, & it will probably shut its eyes to my irregularities!"45
Wellcome himselfsuggested that 'Ifthe matter is presented to the Home Office as a
transfer from 10, Devonshire to 40, Charlotte St. will they not act differently?" and
received the immediate reply from Bokenham that the existing laboratories were not
registered under the Act.46 Chune Fletcher, who had been consulted, raised several
pertinent questions: "How is it that all the present work can be done on unregistered
premises? At what point in vivisection does registration become necessary?"47
Bokenham, however, does not appear to have addressed these points and continued to
take personal issue with the Home Office.
You have refused, & I can only take it that as you now know, even ifyou were before
ignorant, the impossibility ofmycomplying with therestrictions recently imposed, your
42 In 1896, Roy was Professor of Pathology in Cambridge, [Charles Scott Sherrington], 'C. S. Roy
1854-1897', Obit. Not. FRS Lond., 1904, 1: 131-6. AAMR Minutes of the Council and Executive
Committee 1882-1891, 30 May 1890, WI MS 5310 f.58.
43 Op. cit., note 40 above; Bokenham to BW&Co 21 Aug. 1896. WF/180:WPRL.
44"I suppose that Alfred Chune Fletcher, the Medical Officer to the Charterhouse, . . . knew him
[Wellcome] better than anybody else", Sir Henry Dale to Elliott, 6 June 1958. Dale Papers, The Royal
Society (henceforward RS 93HD), T. R. Elliott 36.4.29. The papers were consulted with the permission of
the late Lady Todd and quoted with the permission of the Royal Society. See also WF:C4.WE.HSW/
Friends/Chune Fletcher.
45 Bokenham to BW&Co, 28 Aug. 1896. WF/180 WPRL. The "irregularities" are unclear, unless
Bokenham was carrying out experiments at 10 Devonshire Street. One "irregularity" in the past was an
injection of ortho-nitro-toluidine into a "buck rabit" (sic), in the 'P. Lab.' of the Chemical Works of
BW&Co on 22 February 1890: the animal died with "stentorious breathing". This was clearly illegal, but is
the only account I have found of any such practice. WF/7:Chemical Record Books, p. 179.
46 Op. cit., note 43 above; copy of letter in note 40 above annotated by Wellcome.
47 MemofromTheCharterhouse (Chune Fletcher), undated butitmentions Bokenham andwastherefore
written between 1896 and 1897. WF/180:WPRL.
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persistence in refusing registrationmust be understood as indicating that you have no
REAL desire to bring these testing operations under the regular observation of your
Inspector [all underlined in red by a Home Office official]. Ifyou maintain that I am
in error in this respect, I can only say that the imposition of such impracticable
regulations and vexatious restrictions shows the utter disregard of your department
for the convenience ofmembers ofmy Profession, & a lack ofappreciation on your
part of the value of their time.
He further informed the Home Office that there was no longer adequate space
available for him at either the Conjoint or St Bartholomew's laboratories, and that if
they had not intended to register the Wellcome laboratories, then the Home Office
letter of 4 May (suggesting that Wellcome apply for registration) was "quite
unjustifiable and a deliberate attempt to mislead us and to give us unnecessary
trouble".48 Not suprisingly, Home Office officials considered this to be "an
illmannered letter" although they noted that "it contains the important argument
that the applicant finds it impossible to obtain space for his experiments".49 Despite
Bokenham's assurances that "My authority for this statement is unquestionable"; the
Home Office sought its own verification and eventually concluded that Bokenham
had made no application for further space and was not even using the facilities
already available to him.50
In the meantime, the Wellcome laboratories moved to their newly equipped
premises in Charlotte Street, with stabling facilities for eight horses in Lisson Grove,
and diphtheria antitoxin production continued. Whether Bokenham intended to
proceed with his arguments against the Home Office is not known: several problems
arose with the serum production that may have distracted his, and the Company's,
attention from the problems of registration.
THE LANCET SPECIAL COMMISSION ON DIPHTHERIA ANTI-TOXIC SERUM, 1896
In the middle of 1896, the Lancet published a commissioned report on the relative
strengths ofdiphtheria antitoxins produced by nine institutions,51 ofwhich three were
British: the British Institute of Preventive Medicine (BIPM),52 the Bacteriological
Institute, Leicester,53 and Burroughs Wellcome and Co. The sera from all three were
48 Bokenham to the Home Secretary, I Sept. 1896. PRO H045/11092/B21744/3.
49 HO Memo 4 Sept. 1896. PRO H045/l 1092/B21744/3.
50 Bokenham to the Home Secretary, 7 Sept. 1896; Report by Sir James Russell (HO Inspector for
Scotland) 12 Sept. 1896, affirming that antitoxins should be tested in public laboratories, and reporting
that Dr Noel Paton, Superintendent of the Laboratory of the Royal College of Physicians of Edinburgh,
considered much commercial produce to be worthless and that efforts by laboratories such as his own
should be supported. HO Minute by Digby, 10 Oct. 1896. All in PRO H045/11092/B21744/4.
51 'The Lancet Special Commission on the Relative Strengths ofDiphtheria Anti-Toxic Serums', Lancet,
1896, ii: 182-95. The other companies were Meister, Lucius & Briining, Hoechst-on-Main; Schering,
Berlin; Merck, Darmstadt; Institut Pasteur, Paris; Institut Serotherapique, Brussels; Vogt, Geneva.
Editorial comment, ibid., p.196.
52See note 20 above. When BIPM moved to the Thames Embankment, the HO registration was
transferred to the premises, which included a purpose-built animal house and a small operating theatre.
Pharmaceut. J., 1898, 61: 462-4.
53 Interestingly, this Institutehadbeen established by acommercial company, John Richardson & Co., but
control had been handed over to the Leicester Medical Society: Lancet, 1895, i: 1003; ibid., 1896, i: 569-70;
Chem. & Drug., 1895, 46: 597; ibid., 1896, 48: 356. This was, apparently, at the HO's insistence that the
laboratories be managed in a "scientific" spirit: memo by Poore, 7 Oct. 1896. PRO H045/1 1092/B21744/4.
11E. M. Tansey
belowtheclaimed "strength" (innumbers ofantitoxin unitspervial); the specificcharge
against Burroughs Wellcome and Co. was that instead ofthe advertised 600 units per
vial, thetested strengthwasfrom45 to 300unitsintheliquidserum(6samples)andfrom
40 to 300units in thedried serum (5 samples).54According to the ChemistandDruggist,
this report provided one more example of the "'made-in-Germany' problem which
haunts British technologists", and it was noted that the German Government offered
support and facilities at several levels for the production ofantitoxin far beyond that
available to Britishmanufacturers. Strangely, butperhaps significantly, the problems of
British firms working within the 1876 Act were not mentioned, despite the strong
assertion that "Guinea-pigs are the test-tubes in an analysis of this kind". A
simultaneous report in the PharmaceuticalJournal, about animal-derived therapeutics,
provided a rare acknowledgement that
The preliminary investigations must ofnecessity be carried out by the physiologist, but
the chemical work now falls to the lot of the manufacturing chemist, and as patient
physiological investigations are necessary, they are principally prepared in Germany,
under medical supervision, and without the vexatious interference of the Vivisection
Act.
However, the samejournal's later call for British manufacturers to "set their house in
order" over drug standardization ignored the particular restrictions and problems
imposed by the 1876 Act.55
The Lancet survey provoked questions in the House of Commons about the low
standards of British manufacturers compared with their Continental, particularly
German, counterparts, butagaintherewasnomentionofthelegalconstraints operating
inBritain.56 Thereportcausedaconsiderable stirwithintheWellcomeorganizationand
letters to the Lancet from both the Company and Bokenham questioned the
discrepancies highlighted by the Special Commissioners and offered every facility for
furtherjoint testing under an independent authority.57 Although press commentators
applaudedthis response, itwasrejected bytheLancetasincompatiblewiththecharacter
of their Special Commissions, although it did offer to provide duplicates of their test
samples for re-analysis.58 On behalf ofthe Company, Fletcher Moulton QC MP was
retained for advice to draft a suitable reply to the Lancet.59 Unfortunately, Bokenham,
The Institute produced several antitoxins (Lancet, 1896, i: 788; ibid., 1896, ii: 127, 1484-5), and was
registered from 1895 until 1897. The licensees included C. J. Bond, a later member of the first Medical
Research Committee. See J. B. Walker, 'Charles John Bond of Leicester (1856-1939)', J. R. Soc. Med.,
1984, 77: 316-24; A. L. Thomson, Half-a-century ofmedical research, London, HMSO, 1973, vol. 1, p. 21.
s4 Lancet, 1896,ii: 186-7; theproblemofstrengthwasraisedasearlyasOctober 1894,in'Anti-diphtheritic
serum', Pharmaceut. J., 1894, 54: 291-2.
55 'Aboutdiphtheria-serum', Chem. &Drug., 1896,49:121-2;Pharmaceut. J., 1896,57:84;ibid., 1898,60:
596. A discussion of the limitations of the Victorian and Edwardian education of businessmen may be
found in D. C. Coleman's 'Gentlemenandplayers', Econ. Hist. Rev., 1973, 26: 92-116. Seealso 'A chemical
contrast', Chem. & Drug., 1896, 49: 788-9; and note 137 below.
56 Lancet, 'Report from the House ofCommons', 1896, ii: 418.
57 Bokenham to the Lancet, 1896, ii: 271-2; BW&Co to the Lancet, ibid., p. 272.
58 'The relative strength ofdiphtheria anti-toxin', Pharmaceut. J., 1896, 57: 102; 'Diphtheria anti-toxic
serums', Chem. & Drug., 1896, 49: 223. Lancet, 1896, ii: 316-17.
9 BW&Co to Fletcher Moulton, 31 July 1896, onreceiving a telegram from Wellcome: WF:HSW Letter
Books 1881-1897, S/G/148/2, p. 806. See also H. F. Moulton, The life ofLord Moulton, London, Nisbet
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who took the Commissioners' report and the Lancet's refusal of joint testing
personally, injudiciously claimed, " . . . I know that the results obtained by your
Commissioners are incorrect", and questioned the experience and expertise of the
Commissioners in comparison to his own.60 Not suprisingly, the Lancet responded
strongly to these "preposterous" allegations and maintained that "Messrs.
Burroughs, Wellcome & Co. owe it to theirwell-merited reputation fordrugs that this
question should be placed on some more satisfactory footing."6'
At this point, Henry Wellcome himselfbecame involved in the defence ofthe good
name and the commercial standing of the company, of which he was now the sole
proprietor. He wrote to Bokenham for precise details of the samples tested by the
Lancet, sought the advice ofFletcher Moulton and referred the entire issue to Chune
Fletcher.62 He instructed J. C. Smith from the Company to ascertain what steps
Bokenham had taken and to explore the possibility of an independent referee
re-testing the disputed serum. Smith discovered that samples corresponding with
those tested had not been retained, although it was possible to obtain duplicates from
the Lancet, and reported that he and Bokenham could come to no agreement about a
suitable referee.63
Instead of providing Wellcome with the requested information about serum
samples, Bokenham left the country for a European tour, ostensibly to study foreign
antitoxin production.64 On his return he demonstrated his reluctance to test any
samples that might be obtained from the Lancet, although he created deliberate
confusion about his willingness to do so.65 (Of note here is that Bokenham
performed, or admitted to performing, no testing experiments at all during 1896).66
By the beginning of December 1896, Wellcome was losing his patience and handed
the investigation over to Dr Alfred Kanthack,67
as I am determined that the source of error shall be discovered whether it be on the
side ofthe 'Lancet' or ourselves ... I shall be obliged ifyou [Dr Bokenham] will on
and Co., 1922, particularly 'Lord Moulton and science', pp. 105-45; and WF:HSW/Friends/Lord
Moulton.
60 Bokenham to the Lancet, 1896, ii: 489-90; editorial, ibid., p. 490.
61 Ibid. After a paper by Bokenham at a meeting of the BMA, the Lancet again questioned his
determination of antitoxin strength and reiterated the vital importance of the subject for the medical
profession: Lancet, 1896,1i: 544-5. There was no furthercorrespondence, as Chune Fletcher advised that it
would onlyencourage people tobelieve there was substancein thedebate: "It would be better now to let the
matter drop ifthere is a shadow ofa doubt as to Dr. Bokenham's results". BW&Co to Wellcome, 21 Aug.
1896, WF:HSW Letter Books 1881-1897, S/G/148/2, p. 818.
62 BW&Co toBokenham, 24Aug. 1896, ibid., p. 821. BW&Co to Moulton, 31 July, 19 and 21 Aug. 1896,
ibid., pp. 806, 814, 819-20. BW&Co to Chune Fletcher, n.d., but between 19 and 21 Aug. 1896, asking for
his opinion, ibid., p. 816. See also WF:C4 WE:HSW/Friends/Chune Fletcher.
63 BW&Co to Wellcome, 19 Aug. 1896, WF:HSW Letter Books 1881-1897, S/G/148/2, p. 815.
64 BW&Co to Bokenham, 1 Oct. 1896, ibid., p. 855. "Mr Wellcome quite expected that you would send
brief reports from each place that you visit, a full report being handed in on your return. We call your
special attention to this matter".
65 BW&Co to Wellcome, 19 Aug. 1896, ibid., p. 833; BW&Co to Wellcome, 4 Sept. 1896, ibid., p. 840;
BW&Co to Wellcome, 4 Sept. 1896, ibid., pp. 844--5.
66 See note 30 above.
67 A. A. Kanthack (1863-98) Director of the Pathological Department at St Bartholomew's Hospital,
succeeded C. S. Roy (see note 42 above) at Cambridge: Br. med. J., 1898, fi: 1941-2. Asearly as 16 October
1896, BW&Co asked Chune Fletcher to caution Kanthack about "the matter in hand"; thus negotiations
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hearing from Dr. Kanthack immediately make the necessary arrangements for
carrying the matter through on the lines indicated.68
"The lines indicated" were Wellcome's precise, detailed instructions for analysing the
Lancet's findings. He had considered, and dismissed, the idea of direct prejudice
against the Company on the part of the Lancet, realizing that the wide variety in
reported strength of the tested sera indicated considerable inconsistencies within
Burroughs Wellcome and Co. products, because samples from other companies, tested
in exactly the same way, were not only uniform but ofconsistently higher strength.69
As ifthe Lancet report were not enough, a further blow struck the laboratories on 21
December, when the Company received a letter from Dr J. W. Washbourn, a
prominent bacteriologist:
Dr. Lucas of Burwell, Cambridge sent me an unopened bottle of your Anti-
diphtherical Serum today for examination. I am sorry to inform you that it is full of
bacteria, and consequently unfit for use. I though it wise to let you know at once
because Dr. Lucas has had two deaths from vomiting and diarrhoea occurring shortly
after injection with Serum obtained from your firm.70
Company staffsprang into immediate action, writing to both Washbourn and Lucas,
demanding that Bokenham visit Washbourn to discuss the problem, and sending the
suspect vial to Kanthack for urgent analysis.7'
By this time, the Company had acquired from their salesmen several samples ofboth
liquid and dry serum, six of which corresponded to batches used by the Lancet, and
these were dispatched for re-testing.72 The "Lucas matter" was closely watched, as the
Company realized the serious and damaging nature of the allegations against their
product. They monitored Bokenham's correspondence with Lucas,73 and one report
to Wellcome stressed that "The communication that Dr. Bokenham proposed to send
to Dr. Lucas was an impossible one, and I had no hesitation in at once condemning it. I
hope you will approve the final draft."74 Fortunately for the Company, Lucas,
contrary to Washbourn's advice, decided "for many reasons" not to publish details of
were proceeding several months prior to his open association with the Company: WF:HSW Letter Books
1881-1897, S/G/148/2, p. 864. Wellcome personally contributed to the memorial fund established after
Kanthack's early death: Wellcome to Drysdale, 23 March 1899, WF.C5 HSW: Personal 3 1899-1901, p. 40.
68 Wellcome to Bokenham, 3 Dec. 1896. WF:HSW Letter Books 1881-1897, S/G/148/2, p. 882.
69 BW&Co to Kanthack, 3 Dec. 1896, ibid., p.881. Detailed instructions in 'Antidiptheritic serum', 3 Dec.
1896, ibid., pp. 883-6.
70J. W.Washbourn(1863-1902)waslaterPhysiciantoGuy'sHospital. Oneobituary stressed his "stability
and thoroughness": Trans. epidem. Soc. Lond., 1902, 21: 151-4. Washbourn to BW&Co, quoted in the
letter BW&Co to Bokenham, 22 Dec. 1896: WF:HSW Letter Books 1881-1897, S/G/148/2, p. 903.
71 BW&Co to Wasbourn, 22 Dec. 1896, ibid., p. 904; BW&Co to Lucas, 24Dec. 1896 "certainly no trouble
must be spared to investigate this matter", although the author shrewdly added, "we note that you used
part of the same supply of serum with good results": ibid., p. 910.
72 BW&Co to Kanthack, 23 Dec. 1896, ibid., p. 902.
73 BW&Co to Bokenham, 12 Jan. 1897, ibid., p. 917. Bokenham was sent a draft letter, writing paper,
envelope, and carbon paper for him to write to Lucas and provide a copy for the Company: "the
Laboratories" were apparently not independent enough to have their own stationery. Wellcome to
Dowson, 2 Jan. 1902, WF:E2 DW 'WPRL 1895-1922'.
74 BW&Co to Wellcome, 13 Jan. 1897, WF:HSW Letter Books 1881-1897, S/G/148/2, p. 920.
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the case. The reasons can only be conjectured, although the affair may have reflected
badly on Lucas himself.75
Bokenham's tenure was running out: DrWalter Dowson76 had been "installed as a
pupil under Dr. Kanthack by Mr. Chune Fletcher with the idea ofhis acting for us
either as assistant to Dr. Bokenham, or even if necessary to assume the supreme
control of the Wellcome Physiological Laboratories."77 Louis Cobbett, another
bacteriologist, was also drafted into temporary service although he remained in
Cambridge to perform the necessary analytical work.78 When Cobbett did visit
London, he exacerbated the delicacy of the situation, as Bokenham, despite
forewarning from both Kanthack and Sudlow, gave him "a very cold
reception ... pretending he knew nothing at all about his coming or what he was to
do." For his part, Cobbett indiscreetly revealed that his instructions were from the
Company, and considerable tact had to be exercised "both as regards the visits of
Mr. Cobbett and also with regard to the examination by Dr. Kanthack ofall serums
that were received from Dr. Bokenham, a matter upon which he evidently felt very
sore", although recentdevelopments opened "up a veryencouraging viewwith regard
to the future of the Wellcome Physiological Laboratories."79
Very soon, however, Bokenham was refusing to collaborate with Kanthack,
claiming that the Cambridge test methods were incompatible with his own and
therefore invalid.80 This attitude forced the Company management to intervene
directly once more. "We have to request that you will immediately recommence the
preparation and issue ofthe sera which will continue to be checked as at present."81
Bokenham's misdemeanours did not stop there. He requested, without Company
authority, a sample ofthe Conjoint Laboratories' Diphtheria Toxin, thus attracting
unwelcome publicity,82 and he was reluctant to provide details ofhis procedures and
experiments to either the Company or the Cambridge bacteriologists.83 This state of
affairs continued for a further fewunhappymonths until HenryWellcome could bear
75 BW&Co to Wellcome, 6 Jan. 1897, ibid., p. 915.
76 Dowson(1856-1919)studiedatCambridge,beforepractisingin Bristol. Aninheritanceenabledhim to
work in the Department of Pathology, Cambridge, for a few months and it was there that Wellcome
approached first Cobbett, and then Dowson, to work for him. J. Peile, Biographical register of Christ's
College 1505-1905, Cambridge University Press, 1913, p. 647; Dale to Oakley, 11 Feb. 1966, RS:93HD
65.5, Brockwell Hall, 1952-1967; W. Dowson, "Diphtheria in older and new Bristol', Trans. epidem. Soc.,
1896, 15: 17-47. See also note 206 below.
77 Op. cit., note 74above; this is thefirst reference I can find to the WellcomePhysiological Laboratories.
However, until the move to Herne Hill (see notes 89 and 90 below) there was no consistent title: e.g.,
Wrellcome to Bokenham, 14 Dec. 1896 (WF:C5 HSW Personal 2, 1896-1899, p. 39), referred to the
Physiological Laboratories; and BW&Co to H. E. Littledale, 1 Apr. 1898 (WF:HSW Letter Books
1897-1898, S/G/148/3, pp. 517-8, referred to the Bacteriological Laboratories.
78 BW&CotoBokenham,introducingCobbett, "tocarryoutallexperimentsandworkinconnectionwith
the preparation of serums in every detail, both at the laboratories and at the Stables, that Dr. Kanthack
desires": 19 Jan. 1897, WF:HSW Letter Books 1897-1898, S/G/148/3, p. 927. For Cobbett see the Lancet,
1947, H: 391-2.
79 BW&Co to Wellcome, 27 Jan. 1897, WF:HSW Letter Books 1881-1897, S/G/148/2, pp. 930-3.
80 BW&Co to Kanthack, 13 July 1897, WF:HSW Letter Books 1897-1898, S/G/148/3, p. 42.
81 BW&Co to Bokenham, 22 July 1897, ibid., p. 48.
82 BW&Co to Bokenham, 27 July 1897, ibid., p. 55. Minutes ofCouncil, RCS, 1897-1899, 23 July 1897,
p. 32.
83 BW&Co to Bokenham, 5 Aug. and 24 Sept. 1897, WF:HSW Letter Books 1897-1898, S/G/148/3,
pp. 61, 83; BW&Co to Cobbett, 25 and 27 Sept. 1897, ibid., pp. 84, 86.
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it no longer. At the end ofSeptember, he wrote to Bokenham, urging him to take the
"honourable" course ofresigning, and offered three months' salary plus the month's
salary owing to him and the three month's salary in lieu of notice as agreed in his
contract. Furthermore, Wellcome promised not to mention the manner of
Bokenham's departure, in consideration of his professional position.84 Bokenham's
reply, if any, is not on record.
Laboratory equipment and materials were transferred to Cobbett and Dowson,
who "will take over control of our Physiological Laboratories and Stables" and
formal arrangements were made with Dowson, who was appointed Director of the
Laboratories at the beginning of October85 with the clear proviso, stated in his
contract, that any publications must have Wellcome's approval, and that he was "to
advise us on all physiological questions arising in our business when requested to do
so".86
After these changes the laboratories continued to produce antitoxins and there
were no further major problems about contamination or strength.87 The
arrangements with Kanthack and Cobbett lapsed whilst the demand for serum
necessitated expansion. The facilities in Charlotte Street were seen to be inadequate
and in 1898 the Company began looking for new premises for the WPRL.
THE MOVE TO HERNE HILL AND THE DEVELOPMENT OF RESEARCH
In August 1898, Brockwell Hall in Heme Hill, South London, was identified as a
suitable site, and in November Henry Wellcome acquired a long-term lease on the
property and undertook its extensive conversion, "carried out at very great expense,
and no pains, labour, or money have been spared in rendering the equipment and
appointments most complete."88 By May 1899, Dowson and his small staff had
moved from Charlotte Street89 and it was at this point that the establishment was
publicly recognized as the Wellcome Physiological Research Laboratories.
Descriptions ofthe experimental laboratories, incubation chambers, packing rooms,
and stabling facilities soon appeared in professional journals and in the WPRL's own
publications and advertisments.90 There were facilities for bacteriological, chemical,
84 BW&Co (handwritten by Wellcome) to Bokenham, 29 Sept. 1897, ibid., pp. 93-4.
85 BW&Co to Bokenham, 29 Sept. 1897, ibid., p. 95. BW&Co to Dowson, 29 Sept. 1897, ibid., p. 92;
BW&Co to Roberts, Vallet and Painting, all 30 Sept. 1897, ibid., pp. 99-100. According to WF:P2 Staff
Record Book 1879-1902, p. 45, Dowson was employed from October 1897, although he had been working
in the laboratories for several months. Cobbett was formally employed from October 1897 and left in
January 1898, "As arranged at time of engagement".
86 BW&Co to Dowson, 2 Oct. 1897, WF:HSW Letter Books 1897-1898, S/G/148/3, p. 101.
87 Dowson's response to a complaint, for example, emphasized the precise timing required for successful
treatment and the difficulties of comparing antitoxins in the clinical situation. BW&Co to Waite, 31 Jan.
1897, WF:HSW Letter Books, Dec. 1898 to Jan. 1900, S/G/148/4, p. 94.
88 Therehad beenconsiderable discussion about the lease. BW&Co to Messrs. Markby & Stewart, several
letters, Aug., Sept., and Oct. 1898, WF:HSW Letter Books 1897-1898, S/G/148/3. Undated typescript 'The
Wellcome Physiological Research Laboratories', WF: Strong room 6, drawer 1900: Papers re registration
of WPRL, 1900-01, henceforward WF:WPRL Registration.
89 BW&Co to Dowson at Brockwell Hall, 20 May 1899, WF:HSW Letter Books Dec. 1898 to Jan. 1900,
S/G/148/4, p. 541. The previous letter to Dowson, 14 Apr. 1899, ibid., p. 305 had been directed to Charlotte
Street.
90 Chem. & Drug., 1897, i: 947. On the opening of the WPRL, ibid., 1899, fi: 780-1. The laboratories are
also described in booklets produced by the Company for trade expositions.
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and physiological research, as well as a dark-room and a small library. Initially the
stables, compared to the Queen's stables by one journalist, housed fourteen horses,
several ofwhich were kept under diphtheria treatment for many years. The published
report of the laboratories in the Chemist and Druggist concluded "There can be no
doubt that there is a great future before such work as this in connection with the
practice of physic, and it is gratifying to know that a firm connected with British
pharmacy should be participating in what must be for several years a commerically
unprofitable undertaking."91
The transfer of the WPRL to these larger premises allowed staff expansion.
Dowson was joined in the bacteriological laboratory by A. T. Glenny,92 one of two
schoolboys recruited from the local Alleyn's School,93 the other being A. J. Ewins94
who joined Dr S. N. Pinkus95 in the chemical laboratory. The rest of the staff
comprised the bacteriologist H. J. Sudmersen,96 a general laboratory assistant, and
ancillary workers to look after the animals, prepare the nutritive media, and to bottle
and label the sera. Glenny, who remained with the Wellcome laboratories for his
entire working life, soon realized that the weekly routine of inoculating the horses
with diptheria toxin and bleeding them at irregular intervals was inefficient as the full
bleedings were performed weeks, and sometimes months, after the highest antitoxin
titres had been reached. Thus he introduced a simple "horse-card" for each animal on
which details of all the relevant injections and bleedings could be recorded: this
elementary device greatly increased the production of usable antitoxin.97
Despite the success of the antitoxins, Wellcome had plans for greater
developments, and his concepts of therapeutic advancements emphasized the
necessity for the WPRL to be registered under the 1876 Cruelty to Animals Act. The
91 Chem. & Drug., 1899, 55: 781.
92 C. L Oakley, 'A. T. Glenny (1882-1965)', Biog. Mem. FRS Lond., 1966, 12: 163-80.
93 Alleyn's School arose outofthe "Lower School" ofDulwich College: T. L. Ormiston, DulwichCollege
register 1618-1926, London, Dulwich College, 1925, p. 4. According to Dale, op. cit., note 94 below,
Dowson contacted the Headmaster, Dr Baker, about employing boys with a science background. J. F.
Thorpe, 'H. B. Baker 1862-1935', Obit. Not. FRS Lond., 1935, 1: 523-6, shows that he was Chemistry
Master at Dulwich College until 1902, when he became Headmaster at Alleyn's, although as a Senior
Master at the "parent" school he was probably influential in placing promising pupils. Dale to Poynter, I
Nov. 1960, RS:93HD 65.5, Brockwell Hall, 1952-1967.
94 EwinsworkedattheWPRLuntil 1914,whenhejoinedthestaffofthenewMedical ResearchCommittee
(later Council). In 1917 he moved to May & Baker and produced M&B 693, the potent anti-streptococcal
agent. See H. H. Dale, 'Arthur James Ewins 1882-1958', Biog. Mem. FRS Lond., 1958, 4: 81-91.
95 StanislausNaftelPinkuswasemployed attheWPRLfromSeptember 1898,andleft3 December 1901 to
go into partnership with Schryver ofthe WCRL, Dowson being "far from satisfied" with him. BW&Co to
Wellcome, 22 Mar. 1901, WF:HSW Letter Books c. 1901, S/G/148/0, p. 421, memo. 421.
96 HenrySudmersenwasattheWPRLfrom 1898-1901 and 1905-25(StaffRecordBook,number 1571);he
obtained a Ph.D. in Bern in the interim. BW&Co to Sudmersen, 31 Aug. 1901, WF:HSW Letter Books
June to Nov. 1901, S/G/148/6, p. 355; BW&Co to Sudmersen, 25 July 1905, WF:HSW Letter Books June
to Dec. 1905, S/G/148/9, p. 254; Sudmersen to Dowson, 7 Feb. 1905, WF:K. Dowson regarded him as a
"particularly clever microscopist": BW&Co to Wellcome, 22 Mar. 1901, WF:HSW Letter Books c. 1901,
S/G/148/0, p. 421, memo. 421; and was delighted to re-employ him. Dowson to Wellcome, 27 Feb. 1905,
WF:K.
97 Op. cit., note 92 above, pp. 163-6. Many of the original "horse-cards" and Glenny's notebooks,
including his very first, are in WF/7 ADS Papers and WI/30, Recent Acquisitions: Files of Ehrlich
Collection.
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matter was never entirely dropped after Bokenham's earlier application,98 and by
1899 the expense and inconvenience of performing experimental work at other
registered premises, especially from the WPRL's location in South London, were
becoming obvious.99
Publicity for the new laboratories, such as that quoted above from the Chemist and
Druggist, attracted attention from anti-vivisectionists who, in turn, alerted the Home
Office that serum-testing was being carried out at the WPRL.100 At the end of 1899,
Dowson visited the Home Office Inspector, ProfessorThane, and freely admitted that
such procedures were performed at the WPRL, but he believed that they were not
covered by the Act as they were not calculated to give pain. Once more, Home Office
staffconsulted theprevious LegalOpinions andalthough aHomeOffice official noted
thatit "seemsmorallycertain thatnothingamountingtoillegal infliction ofpain takes
placeinthisestablishment" Thanewasaskedtovisit "iftheFirmwilllethimdoso".101
Thaneacknowledged inhisrequest"thatthepremisesnotbeingregistered, Ihaveno
right ofinspection ... but I am sure that neither Mr. Wellcome nor yourselfwish to
concealyourproceedingsfromtheAuthorities".102Thus, atthebeginningofFebruary
1900, he inspected the laboratories, outbuildings, and stables and "every room and
cupboard in [the] house from roofto cellar".103 Dowson was pleased with the way the
visit went and advised Wellcome that
According to the Inspector our position is this. The law advisers of the crown have
decidedthatitispermissibleundertheexistingstatutetoinjectanimalswithsubstances
in order to immunize them in various ways; but that it is not permissible to inject
98 A note in Wellcome's handwriting 'Dr. Dow[son] is now taking up the matter again with Professor
Michael Foster', 8 Aug. 1899 WF/180 WPRL. Wellcome was not alone in his assessment of future
developments. For example, in July 1895 the Pharmaceutical Society also discussed the need for research
laboratories for investigating new drugs (Pharmaceutical Society, Minutes of Committees 5, 24 Mar.
1890-30 Oct. 1914, p. 74), although their laboratories were not registered until 1926. However, Wellcome
was probably unique as a pharmaceutical manufacturer in recognizing the need for experimentation and
the attendant difficulties.
99 Undated copy of a letter to Sir Matthew White Ridley (see note 31 above). Appendix B lists 31
substances awaitinginvestigation, ofwhich only tetanus C had been tested by Dowson at St Bartholomew's
Hospital. Dowson's licence was available there and at the New Museums, Cambridge (HO Returns
1898-1900. In 1897 it had been available in Cambridge only). The impracticality of working in other
laboratories is further emphasized in an internal memorandum, 20 July 1900, 'Notes re. petition to HO',
probably by Wellcome, WF:WPRL Registration.
100 TheZoophilist, 1 Dec. 1899, reported the opening ofthe WPRL, taken from Chem. & Drug., 1899, 55:
780-1, and the Lancet, 1899, ii: 1456-7. After the latter, Wellcome wrote to the Editor, Thomas Wakely, "I
very much appreciated your article on my Physiological Laboratories contained in the last issue of the
'Lancet'". WF:C5 HSW Personal 3 1899-1901, p. 172. Members ofanti-vivisectionist societies and at least
one MP were also prompted to write to the Home Office about the WPRL. HO to Sandman, 6 Apr. 1900;
HO to the Honorary Secretary of the International Anti-Vivisection Society, 18 Apr. 1900; HO to the
Secretary ofthe London Anti-Vivisection Society, 20 June 1900; HO to Thomas Lough, MP, 2 Aug. 1900.
All in PRO HO156/13, pp. 220, 234, 331, 380.
101 HOmemo 21 Dec. 1899, byThane, ofDowson's visit of 16 December 1899; HO Minute, 17 Jan. 1900.
Both in PRO. HO 45/11092/B21744/6.
102 Thane to Dowson, 3 Feb. 1900, WF/180 WPRL. After the Chem. & Drug., article ofNovember 1899
(op. cit., note 91 above), BW&Co advised Dowson to get an introduction to Thane from either Dr Poore,
Sir Michael Foster or Dr Allbutt and "to put a great deal of stress on the work in chemical physiology
which is carried on at the Laboratories". BW&Co to Dowson, 20 Nov. 1899, WF:HSW Letter Books Dec.
1898 to Jan. 1900, S/G/148/4, p. 864.
103 Dowson to Wellcome, 7 Feb. 1900, WF/180 WPRL.
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guinea-pigs with the serum from these animals in order to ascertain its antitoxic
strength. The latter they regard as an experiment, the former they do not.'04
Thane's report to the Home Office was asenthusiastic as hispredecessor's had been
in 1896: "These are excellent laboratories, Chemical and Bacteriological, well
arranged and equipped for work ofthe highest kind". He also reported positively on
the stabling facilities forthethirty horses underdiphtheria treatment, and thehousing
for the guinea-pigs used in the testing operations, noting that the only other animals
at the WPRL were two goats kept as pets.105 His report concluded that many press
accounts of the laboratories referred to projected work, for which official sanction
would be sought, and that he did not in any way wish to suggest that the laboratories
should be prosecuted. However, he admitted that the testing ofantitoxins under the
1876 Act was still an open question: he believed that as a matter offact, although not
oflegal opinion, diphtheria antitoxins did not cause pain and did not therefore come
under the Act. However, the Law Officers' Opinion of 1896 was used in interpreting
the law, and therefore production of antitoxins could continue quite legally at
Brockwell Hall, but testing and standardization were still to be performed on other,
registered, premises.
THE APPLICATION FOR REGISTRATION, 1900
In February 1900, Wellcome again petitioned the Secretary ofState for the Home
Department, Sir Matthew White Ridley, for the registration of the WPRL.106 He
presented clear scientific and economic reasons for his application, detailing the
outstanding facilities of the laboratories, and stressing the importance of drug
standardization and the urgent need for experimental physiological techniques to
achieve the level of reliability of some imported pharmaceutical products. In
particular, the development and evaluation of new therapies, especially those
associated with animal products, demanded physiological experimentation and
quantification.107 The introduction oflarge numbers ofuseless therapeutic novelties
into Britain could be avoided if proper physiological analysis and testing was
introduced.
It is not going too far to assert that the administration of all powerful remedies to
human beings should first of all have a sound basis in laboratory experiment. This
remark applies equally to that class of remedies in which the relation between the
chemical constitution and physiological action might permit modifications to be
introduced with the result that their usefulness would be greatly enhanced, as to new
therapeutic agents which are from time to time being discovered in the field ofnature
and in the chemical laboratory.'08
104 Notes made by Dowson, 7 Feb. 1900, ibid.
105 HO memo, 9 Feb. 1900, by Thane, of visit to the WPRL. PRO H045/1 1092/B21744/6.
06 Undated petition to Sir Matthew White Ridley, WF:WPRL Registration.
107 HO to Dowson, 16 and 23 Feb., 13 and 15 March 1900, WF:WPRL Registration. Some ofWellcome's
arguments were shared by American Companies. See J. M. Liebenau, 'Scientific ambitions: the
pharmaceutical industry 1900-1920', Pharm. in Hist., 1985, 27: 3-11. The legal context within which
Wellcome worked, however, was substantially different.
108 Typescript draft, 'The Wellcome Physiological Research Laboratories', undated, WF:WPRL
Registration. Wellcome's opinions pre-date the passing ofthe Therapeutic Substances Act (1925), 15 & 16
Geo.V, c. 60, which imposed some standardization on a specified range of products.
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He further maintained "that medical science is entering upon an advanced phase in
which clearly recognised disease conditions are to be met by the administration in
various ways of remedies with definite determined properties in exact doses."'109
Coupled with these scientific justifications was the businessman's argument that the
manufacture offine medical-chemical products in Britain had been severely limited by
the lack of precise physiological testing. "This", Wellcome concluded, "with all it
involves inloss oftrade, loss ofemployment to thecitizens ofthiscountry inafieldwhere
they could excel, and loss of prestige is all the more serious because it is unnecessary."
Similar arguments had been developed in the pharmaceutical press. The Chemist and
Druggist, in noting German provisions for industry, lamented that
With such enterprise and with such scientific resources at command it is not surprising
thatintheproduction offinechemicals British manufacturers have been to a largeextent
beaten out of the field. English discoveries of great practical value have, indeed, been
carried off and utilised by Germans right under our noses.
Their recommendation that Britain needed "firms willing to risk ten, twenty or thirty
thousand pounds annually on what might be unprofitable research" ignored the existing
legal constraints.II
Wellcome's financial ability and willingness to promote such research was also subject
to the additional restrictions of the 1876 Act, and his application for registration
painstakingly distinguished his commercial operations from the research ventures that
he supported, although this seems to contradict some of his previous assertions.11I
These laboratories are entirely separate and distinct from the works and business
departments of Burroughs, Wellcome and Company. They are under independent
direction and areconducted as strictly professional institutions. They are not carried on
as a source of profit but are maintained at a heavy cost by funds derived from other
sources, and like the Wellcome Chemical Research Laboratories (6 King Street, Snow
Hill, London E.C.) have been designed and equipped for research work. At the present
time, however, this research work is fettered and hindered by the inability to carry out
necessary physiological experiments."2
This distinction, ofthe laboratories from the commercial company, was not as clear as
Wellcome seems to have believed and was certainly questioned by many ofhis critics in
themedical profession. Indeed, Dowson checked and tested Company products, ranging
from experimental therapeutics to everyday commodities;113 was frequently asked, as
stipulated in his contract, to advise on Company matters; and was, like all thelaboratory
09 Ibid.; Chem. & Drug., 1896, 49: 121-2.
110 Ibid. An analysis of German research at this time may be found in J. J. Beer, The emergence of the
German dye industry, Urbana, University of Illinois Press, 1959, especially chapter 8, 'The rise of the
industrial research laboratory', pp. 70-93.
lll Similar confusion arose between Wellcome's business and his museums. See H. J. M. Symons, op. cit.,
note 6 above, p. 4.
112 Typescript, op. cit., note 108 above.
113 See, e.g., BW&Co to Dowson, 4 Apr. 1900 (on thyroid glands), WF:HSW Letter Books 1900,
S/G/148/5, p. 529; BW&Co to Dowson, 1 Feb. 1901 (on beef juice), WF:HSW Letter Books c. 1901,
S/G/148/0, p. 36. He also pursued research on shallow burial: see L. J. Picton, Thoughts on feeding,
London, Faber & Faber, 1946, pp. 17-9.
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staff, employed by the Company.114 And after all, the raising ofdiphtheria antitoxin
for sale by the Company had been the raison d'e2tre for the WPRL. Wellcome
consistently stressed that the serum was sold below cost price, and seems to have
equated the absence of profit with divorce from commerce.
Widespreadprejudiceagainsthis"trade" associationsbecamemanifestwhenheand
his staff attempted to rally both direct and indirect support for the registration
application."15 Initially a copy ofWellcome's petition was sent to several prominent
medical men, askingfortheirsupport "Asthe subjectis one ofpractical importance to
themedicalprofession andtothepublic"."16Theintentionwasto approachthirty-five
individuals and four organizations.117 Thecanvassing was unequally divided between
Wellcome himself,118 stafffrom the Snow Hill headquarters, notably J. C. Smith,"19
and Walter Dowson.120 Influential non-medical support was also sought from A. J.
Balfour and Lord Rosebery, although both declined to sign the petition.121
The original application was laid before the Home Department on 15 February
114 For details of his employment see notes 76 and 85 above. The use of "commercial contracts" for
scientific staffwas to prove irksome. Dowson was expected to make reports to BW&Co on WPRL staff,
e.g. BW&Co to Dowson, 9 Jan. 1900, WF:HSW Letter Books 1900 S/G/148/5, p. 22; and BW&Co staff,
usually J. C. Smith, made regular visits to the WPRL, e.g. BW&Co to Dowson, 21 Nov. 1900, WF:HSW
Letter Books 1900-1901, S/G/148/1, p. 461.
115 Typescript draft, op. cit., note 108 above. BW&Co donated medical equipment to the city ofLondon
Volunteers going to the Boer War: Chem. & Drug., 1900, 56: 48; and prominently advertised WPRL sera at
tradeexhibitions, e.g., ibid., 1901, 58: 441. Sub-letting ground at Brockwell Hall was considered as a means
to gain local support; BW&Co toWellcome, WF:HSW Letter Books 1900-1901, S/G/148/1, p. 959, memo.
245.
116 DowsontoBW&Co, 31 Jan. 1900,enclosingacopyofthepetition totheHOandtheletteraddressedto
medical men, WF:WPRL Registration.
117 The list accompanying the documents referred to in the above note includes the names of Sir John
Burdon Sanderson, Regius Professor of Medicine, Oxford; Francis Gotch, Professor of Physiology,
Oxford; W. S. Church, President ofthe Royal College ofPhysicians; E. A. Schafer, ProfessorofPhysiology
in Edinburgh; and Sir Michael Foster, Professor of Physiology, Cambridge. All would ultimately sign
Wellcome's petition. The name of"Mrs. Garrett Anderson, M.D." is listed but crossed out. The Societies
listed are the Incorporated Society of Medical Officers of Health; the Society for the Advancement of
Medicine by Research (sic), the Pharmaceutical Society and the Society of the Chemical Industry,
WF:WPRL Registration.
118 WellcomeobtainedthesupportoftheLancet'sEditor,ThomasWakley. Wellcome toBW&Co, 16Feb.
1900, WF:WPRL Registration.
119J. C. SmithsoughtsupportfromJ.WardCousins, PresidentoftheBMA,telegram Burcome(BW&Co)
to Wellcome, 20 Feb. 1900; Sir Thomas Clifford Allbutt, Allbutt to BW&Co, 26 Feb. 1900; Mr
Sandemann, Chairman ofthe London Chamber ofCommerce, BW&Co to Dowson, 2 Mar. 1900; E. M.
Holmes, President ofthe British Pharmaceutical Conference 1900, Holmes to BW&Co, 1 and 3 Mar. 1900.
All in WF:WPRL Registration. Ward Cousins, Allbutt, and Holmes signed the petition (Haggis, op. cit.,
note 5 above, pp. 343-4); Smith accepted that they signed as private individuals, not for their respective
organizations, e.g. BW&Co to Holmes, 2 Mar. 1900, WF:HSW Letter Books 1900, S/G/148/5, p. 246.
120 Dowson approached Dawson Williams, Editor of the British Medical Journal; and E. C. Seaton,
President ofthe Council ofthe Incorporated Society ofMedical Officers ofHealth (Dowson to BW&Co,
23 Feb. 1900); Lord Avebury, Chairman ofthe Associated Chamber ofCommerce (BW&Co to Dowson, 2
Mar. 1900); Victor Horsley (BW&Co to Dowson, 9 Mar. 1900; Dowson to BW&Co, 11 Mar. 1900. All in
WF:WPRL Registration.) Dawson Williams, Seaton, and Horsley signed the petition: Haggis, op. cit., note
5 above. p. 344.
121 Both were articulate proponents oftechnical education. A. J. Balfour, laterPrime Minister(fromJuly
1902 to December 1905), had "every sympathy with the objects you have in view" but felt unable to sign a
memorial addressed to a colleague: Balfour to Dowson, 20 Feb. 1900. Lord Rosebery had been
Parliamentary Under-Secretary at the Home Office (1881-3). He refused to sign, claiming to have no
influence: Rosebery to Dowson, 19 Feb. 1900. WF:WPRL Registration.
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1900; Dowson forwarded additional signatures the following month.'22 Eighteen
prominent doctors finally supported Wellcome; not all those approached had felt
able to sign.123 Sir Dyce Duckworth, Honorary Physician to the Prince ofWales, and
Treasurer of the Royal College of Physicians and its representative on the General
Medical Council,'24 felt that the restrictions and difficulties placed on "Professors
and Teachers in our great Schools of Medicine and Universities" were almost
insuperable and that it was therefore unreasonable to request additional facilities for
"firms engaged in business" although he recognized that Burroughs Wellcome and
Co. did excellent work. He also raised the question that would recur throughout the
period ofWellcome's application-ifthe Home Secretary didregister the WPRL, the
privilege could not then be withheld from other, "inferior" firms.'25 Dowson
received this opinion with considerable dismay and immediately refuted some ofthe
objections: "my own feeling is, and this was the point which weighed with those who
have already signed, that theprinciple ofthe thing is right, and that results would be
good both for the medical profesion and for the public." He argued that those who
would benefit most from the registration of the WPRL and other "commercial"
laboratories would be the sufferers from disease, "not to mention the advantages
which must accrue to the science of a very difficult subject"'.'26
Within the Wellcom.e organization, it was thought that the application would go
before the Home Secretary himselfwho would then pass it to the Law Officers ofthe
Crown or to the Association for the Advancement of Medicine by Research
(AAMR). Dowson knew that the latter had been approached when the Clinical
Society requested registration, but there is no record that they were involved with the
Wellcome application, and in view of its generally facilitatory role and the fact that
many of its members had signed Wellcome's petition, it seems unlikely that its
opinion was canvassed.'27
In May 1900, Dowson's contract was extended for three years, and he was
providedwithaletterofindemnity,approvedbytheCompany'slegaladvisers,inwhich
"[we] recognise our obligations to you in all such work performed in our
Laboratories ... and we undertake to pay any fines, expenses, and any other fit and
122 Dowson to Ridley, 15 and 22 Feb. 1900, both in PROH045/11092/B21744/8; HO to Dowson, 16and
23 Feb. 1900, 13 and 15 Mar. 1900, all in WF:WPRL Registration.
123 In addition to those mentioned in notes 117 to 120above, supporters were C. M. Chadwick, Professor
ofMateria Medica, Pharmacology &Therapeutics, Yorkshire College, Leeds; Julius Dreschfield, Professor
of Medicine, Victoria University, Manchester; Ray Lankester, Professor ofPhysiology and Comparative
Anatomy, Royal Institution; Lord Lister, President of the Royal Society; E. H. Starling, Professor of
Physiology, University College London; G. Sims Woodhead, Professor of Pathology, Cambridge; and J.
W. Moore, President of the Royal College of Physicians of Ireland: Haggis, op. cit., note 5 above, pp.
344-5. Sir Michael Foster was closely involved in drafting suitable replies to the Home Office and had
publicly praised "Wellcome & Burroughs" (sic), Chem. & Drug., 1899, 54: 796.
124 Munk's Roll, 1926, 4: 179-80; and DNB.
125 Duckworth to Dowson, 12 Feb. 1900, WF/180 WPRL.
126 DowsontoDuckworth, 24 Feb. 1900,WF/180WPRL.ThereisnothingtosuggestthatDuckworthwas
swayed by this appeal, and an obituary commented that he "always rather mistrusted the laboratory":
Lancet, 1928, i: 210-1.
127 BW&Co toWellcome, 17 Feb. 1900, WF:HSW Letter Books 1900, S/G/148/5, p. 192, memo. 211. For
the role of the AAMR see French, op. cit., note 3 above, pp. 177-219; and Vine, op. cit., note 22 above,
pp. 10-1. The AAMR Minutes Books for this period have not been located.
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proper charges which may be incurred by you in connection with such work.. .
The accompanying contract specified that, because ofthis letter, all Dowson's work
should bestrictly subject to theCompany's sanction and all scientificcommunications
should likewise have the direct approval of Wellcome himself or his company
representatives. 128
THE RESPONSE OF THE HOME OFFICE AND THE ROLE OF THE ROYAL COLLEGES
Wellcome's application was immediately referred to Professor Thane, who agreed
thatdrugstandardizationwasofconsiderableimportance, butexpresseddoubtsabout
permitting one firm to perform the work as this would undoubtedly confer a
commercial advantage. He suggested that three questions be addressed to the Royal
Colleges of Surgeons and of Physicians, and that the second and third also be put
before the Pharmaceutical Society, admittedly "anassociation oftradesmen", but one
nevertheless affected by the application.'29 The Home Secretary acted upon this
advice, and asked
1. Is the standardisation ofdrugs by means ofexperiments onanimals indispensable
in the public interest?
2. Ifso, is it probable that, in proper cases, duly-qualified experimenters working in
the premises of manufacturing chemists should be empowered to perform the
necessary experiments on animals for this purpose?
3. Ifitisnot thought desirable thatmanufacturingchemists should beentrusted with
this power, what other provision is it advisable and practicable to make for the
purpose?'30
The Council of the Pharmaceutical Society promptly replied that they did not
consideritdesirable thatexperimental workbecarried outincommerciallaboratories,
and suggested that theexisting arrangements between Parke Davis and Companyand
the Conjoint Laboratories could be extended to other manufacturers.13' Both Royal
Colleges referred thequestions to theirjoint Laboratories Committee,'32 although the
privatecorrespondence ofW. S. Church, President ofthe Royal College ofPhysicians,
with Digby of the Home Office, indicates his opposition to the registration of a
commercial laboratory, althoughhehadsignedWellcome'spetitionearlierintheyear.
128 BW&Co to Wellcome, 27 Apr. 1900, WF:HSW Letter Books 1900, S/G/148/5, p. 547; BW&Co to
Dowson, 22 May 1900, ibid., p. 668; BW&Co to Dowson, 22 May 1900, ibid., p. 662. It was only after
registration that papers openly acknowledged the WPRL. Bokenham, for example, always published as a
'Late Research Scholar, British Medical Association', and credited BW&Co in his texts, but never in his
title: e.g. Br. med. J., 1895, ii: 416; ibid., 1896, ii: 3-4; ibid., 1897, ii: 1277-8. Whether such reticence was
associated with the difficulties with the Home Office is not known.
129 HO MinuteanddraftbyThane, 1 Mar. 1900, PROH045/11092/B21744/8. Hediscussedestablishing
an independent testing station with the Pharmaceutical Society and the RCS.
130 Home Secretary to RCS, 30Apr. 1900, Minutes ofCouncil RCS, 1899-1901, p. 190. In 1900 the RCS
celebrated its centenary, and an article by V. Plarr, 'The centenary of the Royal College of Surgeons of
England', Nature, 1900, 62: 294-6, emphasized its role in the development ofscience, and as a guardian of
medical ethics.
131 Pharmaceutical SocietytoHO, I0May 1900, PROH045/1 1092/B21744/16,enclosinganadvertisment
placed by Parke, Davis & Co. in Br. med. J., 1900, i: 88.
132 Thelaboratories weremanaged byaCommitteerepresenting bothCollegesandin 1900consistedofDr
Pye-Smith (Chairman), Drs W. D. Halliburton and S. Martin (from the RCP) and Sir William
MacCormac, H. G. Howse and H. Morris (from the RCS). Minutes ofCouncil, RCS, 1899-1901, p. 164.
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Church also raised the possibility ofeither the Conjoint Laboratories or the Jenner
Institute becoming Official Testing Stations, although he stressed that pecuniary
assistance would be necessary.133
The Laboratories Committee reported in July 1900. While supporting the need for
some animal experimentation fordrugstandardization, it regarded "the authorisation
of the necessary experiments in the premises of manufacturing chemists as highly
undesirable".134 Perhaps not too surprisingly, the Committee praised the work ofthe
Royal Colleges, which in the public interest and without financial advantage had for
many years produced and tested serum at stables made available by the Metropolitan
Asylums Board and funded by the Goldsmiths Company.'35 It explained the existing
provision of a Testing Service for other manufacturers' serum, and suggested that
such "independent" validation was more authoritative than any performed by the
manufacturers themselves.136 This arrangement was already working well with Parke
Davis and Company.'37
These reports came to Wellcome's attention and he realized that the Home Office
would require additional reasons before granting registration.138 A draft document
prepared by the Wellcome organization emphasizes that the work undertaken at the
WPRL should not be misunderstood. "Research work is not a thing which can be
made to pay and these departments are carried on as strictly ethical institutions quite
distinct from manufacturing departments."'39 Perhaps to highlight this point, the
Company sought press coverage of the work of the WCRL, which had actually
moved to new premises some months previously. The resulting reports, which
fortuitously praised the scientific quality ofthe work and the professional standards
of the staff, and lauded "Mr. Wellcome's public spirit", also emphasized the
independence of these laboratories from the Company: "the clovenhoof of
commercialism has not appeared in Mr. Wellcome's scheme".'140
A concerted effort was now made to achieve registration: staffofboth the WPRL
and the WCRL were asked to submit ideas for a newpetition and Fletcher Moulton's
133 Church to Digby, 7 May 1900; Digby to Church, 12 May 1900; Church to Digby, 13 May 1900. All in
PRO H045/11092/B21744/15.
134 Report ofthe Laboratories Committee, Minutes ofCouncil, RCS 1899-1901, 3 July 1900, pp. 221-3.
See also the Lancet, 1900, ii: 338, and note 150 below.
35 Minutes of Council, RCS 1893-1895, 8 Mar. 1895, pp. 354-6.
136 Minutes ofCouncil, RCS 1897-1899, 10 Mar. 1899, p. 308. The fee depended on the strength ofthe
serum.
137 E.g., MinutesofCouncil, RCS 1899-1901, 5 Oct. 1899, p. 61. Seealso Chem. & Drug., 1898,53:182-3;
ibid., 1899, 54: 896. Both articles praise Parke Davis & Co.'s physiological testing(although products other
than serum were tested in America). Three years later a similarly laudatory report did recognize the
difficulties facing British manufacturers: "Physiological tests made in this country by pharmacistswould, I
presume, infringe the Vivisection Act"; ibid., 1902, 61: 892.
138 On receiving the Laboratories Committe report, the Home Secretary decided to reject the WPRL's
application and appropriate letters to Wellcome, the Royal Colleges and the Pharmaceutical Society were
prepared. All in PRO H045/11092/B21744/20. Dowson's visit of27 July 1900 prevented these being sent.
See note 144 below.
139 'Notes re. petition to HO', typescript, probably by Wellcome, dated 20 July 1900, WF:WPRL
Registration.
40 BW&Co to Editor, Pall Mall Gazette and other newspapers, 4 July 1900, WF:HSW Letter Books c.
1901, S/G/148/0, p. 871; Brit. & Col. Drug., 1900, 37: 751-2; Pharmaceut. J., 1900, 64: 676-7; and Chem. &
Drug., 1900, 56: 1028-9.
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legal advice was sought once again.'4' Dowson was dispatched for an informal talk
with ProfessorThaneat University College, withinstructions towithdrawthepetition
rather than risk an outright rejection, ifthat seemed the likely outcome.142 This visit
was to prove ofcritical importance as Dowson realized "that a crisis was on us" and
after appealing to Thane "as one scientific man to another", he learnt that a formal
letterofrefusal was aboutto besenttoWellcomefromtheHomeOffice. Dowson sped
to the Whitehall office of Sir Kenelm Digby, and after a lengthy discussion during
which he extracted the admission that the Wellcome petition "was one of the more
important and one of the most difficult to deal with that they had before them for
years", he finally persuaded Digby not to send the letter and to allow Wellcome more
time to supplement his petition.'43
An even more significant outcome of this visit was Dowson's declaration of
readiness to testify that the diphtheria antitoxin testing procedures were painless, if
legal proceedings were taken against him. Digby recorded that "Dr Dowson has
thrown down a distinct challenge to the Home Office to test this, and I cannot blame
him for doing so. It seems to me a perfectly open and straightforward course to
take."'44 However, as Digby wrote, it would pose several problems for the Home
Office: proceedings could indeed be initiated, but it seemed unlikely that the
prosecution would be successful, particularly as Thane was not prepared to argue that
such procedures were painful. A failed prosecution would open the Home Office to
complaints from anti-vivisection groups that they had not been consulted, and such
conflict should be avoided ifpossible. The Secretary ofState could once more refer to
the Law Officers and ask for specific advice about a prosecution. Alternatively, ifthe
matterwas now too important forthe HomeOfficealone, a stronginter-departmental
committee should be established to consider the broader issues ofscientific advances
and their commercial applications, and non-scientific men, including opponents of
animal experimentation, should be invited to participate.'45
Meanwhile Dowson's report toWellcomelisted the fundamental quetions raised by
the Home Office:
1. Whycould Dowson notdo the required work at St Bartholomew's orthe
Conjoint Laboratories?'46
2. Could the Royal Colleges provide all the necessary facilities and if so,
would they?'47
3. Would Wellcome gain a valuable monopoly ifthe Home Office granted
this petition?
141 BW&Co to Moulton, 24 July 1900, WF/180 WPRL.
142 BW&Co to Dowson, 27 July 1900, WF:HSW Letter Books 1900, S/G/148/5, p. 952.
143 Dowson to Wellcome, 27 July 1900, WF/180 WPRL.
144 HOmemobyDigby,30July 1900,about Dowson'svisitof27July 1900. PROH045/1 1092/B21744/20.
145 Ibid.
146 Dowson's licence wasavailable at St Bartholomew's but not at the Conjoint Laboratories. See note 99
above for more details.
147 TheConjoint Laboratories didhavefacilities butwereextendingtheir own serum production: see note
149 below.
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4. How many other manufacturers would request the same privileges?'48
5. Would the granting of registration confer an indirect guarantee of
Wellcome's product?
6. Why could not all the serums be tested at the Conjoint Laboratories?'49
Dowson had gleaned useful information from his informal meetings. The Home
Officewould only act positively ifthe medical profession fully and publicly supported
Wellcome, and as articles in the medical press a fewweeks laterindicated, this was not
so.150The ChemistandDruggist, reporting aspeech ofDrChurch'5' at adinnerofthe
Pharmaceutical Society, commented that it was an open secret that the Society
opposed Wellcome's application and now that the Laboratories Committee was of
the same opinion, it boded ill for manufacturers. Ifthe Home Secretary acted on the
recommendations and refused registration, then the raising and standardization of
antitoxins would be substantially handicapped.'52
Wellcome's response to this barrage ofnew information was immediate: he wrote
to the Home Office formally asking for more time to supplement his petition,'53 and
he initiated enquiries both at home and abroad in search ofadditional support and
information.
THE CAMPAIGN FOR FURTHER SUPPORT
Wellcome's overseas agents indicated that legal curtailment of medical research
was unknown elsewhere and in particular praised the German policy ofencouraging
technical education and research.154 Enquiries in Italy, France, and Switzerland
about animal experimentation155 and legal requirements for drug, serum and
148 Asdiscussed below,questions3and4seemcontradictory. The HomeOfficewasconcerned not toseta
precedent for other companies by registering the WPRL, but at the same time did not want to provide
Wellcome with a virtual monopoly.
149 J. C. Smith reported to BW&Co that the Conjoint Laboratories' expansion at Balham might be to
provide a Government Testing Station for serum, BW&Co to Wellcome, 25 Jan 1901, WF:HSW Letter
Books c. 1901, S/G/148/1, p. 958, memo. 242. This did not occur, but the additional stabling achieved HO
registration without debate: HO Returns, 1903.
'50 Lancet, op. cit., note 134above; Chem. & Drug., 1900,57: 283-4; Br. med. J., 1900,ii:447-8. Wellcome
believed the Lancet report to be the most accurate account ofthe Committee meeting, but a comparison of
all three with the Committee report shows that of the British Medical Journal to be closest.
51 Chem. & Drug., 1900, 56: 838-9.
152 Dowson believed that the Royal College ofPhysicians (RCP) was interested in extending the law and
that the RSC was more hostile: Dowson to BW&Co, 27 July 1900, WF/180 WPRL. Ironically, 30 years
later Wellcome achieved the distinction, rare for a non-medical person, of election as a Fellow of the
College. WF: C4 WE:HSW/Societies/R C Surg.; Plarr's Lives, (1930-51), pp. 831-3. The relevant
documents have not been located in the Archives of the Pharmaceutical Society; I thank their Archivist,
Miss K. Arnold-Foster, for her assistance.
153 HSW toHO, 30July 1900. Theextension wasreadilygranted: HO toWellcome, 3 Aug. 1900, WF/180
WPRL.
154 Ulan to Wellcome, 21 July 1900; Linkenheil & Co., Berlin to BW&Co, 23 Aug. 1900, WF:WPRL
Registration. The German company Bayer A.G. established research laboratories in the 1860s and
employed professional scientists without restricting their work. G. Meyer-Thurow, 'The industrialization
of invention: a case study from the German chemical industry', Isis, 1982, 73: 363-81.
155 Raffo Dalmazzo & Co. to BW&Co, 13 and 28 Aug. 1900. No law applied in Italy, "whatever is
required" being allowed; 'Harry' in Paris to BW&Co, 23 Aug. 1900, reported "There is ofcourse a general
law against cruelty to animals, but this is never put into action in the case of experiments made with an
object ofpublic utility"; J. G. Jeffcoat (Export & Commission Agent) to BW&Co, 24 May 1900; 'Harry' to
BW&Co, 29 Aug. 1900; Institut Pasteur to BW&Co, 20 Nov. 1900; Auguste Aman, Lausanne to BW&Co,
26The Wellcome Physiological Laboratories
chemical standardization156 also revealed no restrictions. In America there were
relevant statutes about the cruelty to animals only in the states ofMassachusetts and
Washington, although there were no specific provisions against scientific work.'57
It is worth considering whether prejudice existed against Wellcome, not just as a
"tradesman", but as an American. Although Wellcome was a prominent member of
the American Society of London, and there had been an earlier suggestion that
Burroughs Wellcome and Co. had been subject to nationalist prejudices, Wellcome
himself stoutly maintained, "I have never had reason to feel myselfeither a stranger
or a foreigner in this country". No evidence has been found amongst Home Office, or
any other, records that Wellcome was discriminated against as a foreigner (although
see below on the comments expressed in 1905), and contemporary accounts of
American business activities were usually favourable. Lord Rosebery, for example,
used a particularly apt analogy: "In these days we need to be inoculated with some of
the nervous energy ofthe Americans".158 What was ofconcern in Britain at this time
were the activities of the various anti-vivisectionist movements and Wellcome had
been especially annoyed at the way his Company's policy ofcheap serum had been
cynically disparaged in the Abolitionist.159 This attack was particularly inopportune
as it occurred whilst the registration petition was under Home Office consideration.
However, Dowson's Whitehall contacts advised him that they were actually more
afraid ofrepeating the "Coal-Tar Industry mistake",'60 a reference to the decline of
that industry despite its calls for Government support. Wellcome's staff considered
several ways inwhich theircase forregistration ofthe laboratoriescould be advanced.
One plan was to issue explanatory booklets to all medical practitioners in Britain:
eventually, more discreet advertising methods were employed.'6'
17 Sept. 1900. All in WF:WPRL Registration. BW&Co also wrote (13 Aug. 1900) to its Austrian and
Belgian agents, but there is no record of replies: WF:HSW Letter Books 1900-1901, S/G/148/1, p. 20.
1'6BW&Co to the agents listed in notes 154 and 155 above, 2 Oct. 1900, ibid., pp. 245, 247-50.
157 Cody to Power, 23 Aug. 1900; Power to BW&Co, 24 Aug. 1900, WF:WPRL Registration; BW&Co
to Power, 11 Aug. 1900; WF: Letter Books 1900-1901, S/G/148/1, p. 18.
158 'Mr. WellcomedoesnotcomplainofBritishinjustice', Chem & Drug., 1896,48:63; Lord Rosebery(see
note 121 above) The Times, 16 Oct. 1901, quoted and discussed in R. H. Heindel, The American impact on
Great Britain 1898-1914, Philadelphia, University of Pennsylvania Press, 1940, p. 215. See also J. H.
Dunning, American investment in British manufacturing industry, London, George Allen & Unwin, 1958,
pp. 62-3.
159Wellcome to BW&Co, 11 Sept. 1900, WF:WPRL Registration; Abolitionist, 15 Aug. 1900, p. 1.
Wellcome was a Life Member and Vice-President ofthe Research Defence Society (RDS): RDS Quarterly
Report, 1913. In 1980, the Wellcome Foundation (successor to BW&Co) were, with Glaxo and ICI, the first
Company Members of the RDS. Information courtesy of The Council of the RDS. In its campaign for
support, BW&Co had been especially careful not to attract anti-vivisectionist attention: BW&Co to
Dowson, 3 Mar. 1900, WF: Letter Books 1900-1901, S/G/148/5, p. 259. See also note 100 above.
160 Op. cit., note 143 above. See, e.g., R. Meldola, 'The scientific development of the coal-tar industry'
(1886), reprinted in W. M. Gardner (editor), The British coal tar industry; its origin, development and
decline, London, Williams & Newgate, 1915, pp. 121-40. Another writer noted, "the coal industry has
given birth during recent years to several important daughter industries. . . the most important is the
manufacture ofsynthetic medicinal preparations, which ... bids fair to revolutionise medical science": A.
G. Green, 'The relative progress ofthe coal-tar industry in England and Germany during the past fifteen
years' (1901), reprinted inibid., pp. 189-203. Concern was frequentlyexpressed in thepharmaceutical press
about the low status of British science, particularly when compared with Germany, e.g. Chem. & Drug.,
1896, 48: 78-9.
161 E.g., BW&Co to Dowson, 19 Oct 1900, WF:HSW Letter Books 1900-1901, S/G/148/1, p. 310.
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The Home Office had, of course, taken considerable notice of the opinions
expressed by the two Royal Colleges. Dowson's private informants, as well as
Fletcher Moulton, suggested that approaches should be made to all members of the
Laboratories Committee, "in the hope of converting them from their conservative
opinions, as probably their conversion means to us success or failure in this
petition."'162 Thus Dowson began to visit and correspond with several prominent
doctors and members of the Laboratories Committee; and his confidential notes to
the Company'63 and subsequent report to WellcomeM 64indicate not only the extent of
his canvassing but also the range of opposition that the WPRL faced from the
medical authorities.
The Chairman of the Laboratories Committee, Dr P. H. Pye-Smith, was initially
reluctant even to discuss the problem, claiming that "It is an official matter entirely".
He relented eventually but argued that the precedent of the WPRL's registration
would result in the granting ofsimilar applications with no guarantee as to the quality
of staff or facilities. The only retort that seemed to influence him was Dowson's
reminder that licence and certificate applications had to be supported by responsible
members ofthe profession. At the end ofthe interview he promised that "he would do
what he could".165
The other member of the Laboratories Committee interviewed by Dowson, Dr
Sidney Martin, was in "most decided and fixed opposition to Mr. W's desire", and
although he expressed satisfaction with the work of the WPRL, he too believed that
the Home Office might proceed to register inferior laboratories. The argument that
Dowson had used so convincingly with Pye-Smith failed to satisfy Martin, who cited
Bokenham as a conspicuous example of the failure to maintain standards.'66 Martin
also doubted the independence of laboratories associated, however tenuously, with a
commercial company, and he challenged Dowson to say whether, if a new method of
precipitating and drying antitoxins was discovered in the WPRL laboratories, it
would be published immediately. When Dowson replied "no", Martin re-emphasized
his opposition to the registration ofany but a purely scientific institution. He thought
that it would be some time before such laboratories as the WPRL would be registered,
although he also believed that the Home Office would not interfere with their present
production of antitoxin.167
The Director of the Conjoint Laboratories, T. G. Brodie, while friendly towards
the WPRL, was concerned that "We medical men must take care that experimental
science, especially biological science, is not made subservient to commercial
162J. C. Smith's notes of an interview with Chune Fletcher and Fletcher Moulton, 20 Dec. 1900,
WF:WPRL Registration.
163 BW&CotoWellcome, 11 Jan. 1901. WF:HSWLetterBooks 1900-1901, S/G/148/1,p. 859,memo. 182.
In Wellcome's writing at the side of this assertion, "Noted but do not be discouraged right will prevail".
64 Notes from Dowson to BW&Co, 25 Jan. 1901, WF/180 WPRL.
165 Ibid., notes of an interview, 28 Dec. 1900 with "A", i.e. Dr P. H. Pye-Smith, Chairman of the
Laboratories Committee and prominent member of the RCP to whom Dowson had been introduced by
Allbutt, BW&Co to Wellcome, 31 Dec. 1900, WF: Letter Books 1900-1901, S/G/148/1, p. 743, memo. 100.
166 Martin does not seem to have realized that it was because Wellcome wished to be seen to be within the
law that he was applying for registration.
167 Op. cit., notes 163 and 164 above. Notes ofa long interview with "G" (Dr Sidney Martin), 8 Jan. 1901,
at which time he was Professor of Pathology at UCL.
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interests", and was anxious to know how testing experiments were done at the
unregistered premises of the WPRL. Dowson replied that such experiments did not
give pain and were therefore outside the 1876 Act. Although Brodie agreed, he
warned that many otherphysiologists did not, and that Martin, in particular, believed
strongly that such work was painful and should come under the 1876 Act. Brodie
alreadyknewthattheHomeOfficehadwritten to several leadingbacteriologists about
this, and Dowson warned the Company that a directive might therefore be expected
any day from the Home Office, stopping such work at the WPRL.168 Wellcome's
handwritten comment at the side ofthis report is emphatic: "I shall seriously consider
the question ofestablishing physiological testing laboratories abroad ifwe finally fail
to get justice at home."'169
The wariness of"commercial links", expressed by Pye-Smith, Martin, and Brodie,
was repeated by Frederick Hewitt170 but Dowson's other contacts supported the
application. Anthony Bowlby was "frankly on the side of the WPRL all along the
line"';'71 Dr Frederick Andrewes's response was, "you have not to convert me in this
matter'; 172 and Dr Stewart was "entirely on the side of the WPRL".173 Frederick
Gowland Hopkinsactuallyindicated thathadDowson, ratherthanWellcome,applied
for registration, the commercial associations would have been obviated, and the
procedure would have been easier.174
Wellcome's "trade" associations were simultaneously causing problems with the
British MedicalJournal. Its BusinessManagerrefusedtoprovideoffprints ofpapersby
members of the WCRL, as he considered them to be commercial advertisements.
168 op. cit., notes 163 and 164 above. Notes ofan interview, 4 Jan. 1901, with "F", Dr T. R. Brodie, who
objected that other firms would demand the same privilege if the WPRL were registered.
169 BW&Co to Dowson, 25 Jan. 1901, WF:HSW Letter Books 1900-1901, S/G/148/1, p. 966; BW&Co to
Wellcome, 1 Mar. 1901, suggests moving to Milan, WF: Letter Books c. 1900, S/G/148/0, p. 253, memo.
341.
170 Op. cit., note 164above. Notesofaninterview, 9Jan. 1901, with "H", DrFrederick Hewitt, "averyold
friend and now eminent in the medical world". Knighted in 1911, he became anaesthetist to Edward VII.
Lancet, 1916, i: 157-61.
171 Op. cit., note 164 above. Notes ofaninterview, 28 Dec. 1900, with "B", MrAnthony Bowlby, surgeon
to St Bartholomew's Hospital and also on active service in South Africa. He promised that he would see
"C" and "D" (Drs Norman Moore and A. Willett) and advised Dowson to talk with "E" (Dr Frederick
Andrewes). Moore was a prominent member of the RCP, and lecturer and assistant physician to St
Bartholomew's; Willett was a Member of Council of the RCS from 1887-1903. Dowson's interview with
Moore confirmed that any decision of the Laboratories Committee would have to be ratified by the
Colleges' Councils before going to the HO: BW&Co to Wellcome, 8 Feb. 1901, WF: Letter Books c. 1901,
S/G/148/0, p. 86, memo. 291. See also note 172 below.
172 Op. cit., note 164 above. Notes of a "long interview", 3 Jan. 1901, with "E", i.e. Dr Frederick
Andrewes, who immediately wrote an introduction for Dowson to Dr Sidney Martin: see note 166 above.
Andrewes, later knighted, was a pathologist and bacteriologist, Kanthack's successor at St Bartholomew's:
see note 67 above.
173 Op. cit., note 164 above. Note ofan interview with "L", 22 Jan. 1901, probably Charles Stewart, FRS
(1840-1907), Professor ofComparative Anatomy and Physiology at the RCS: J. Dobson, 'Conservators of
the Hunterian Museum. V. Charles Stewart', Ann. Roy. Coll. Surg., 1962, 31: 46-51. Dowson requested an
introduction to H. G. Howse, Surgeon toGuy's and a member ofthe Laboratories Committee, but Stewart
was unable to oblige.
174 Op.cit.,note 164above. Notesofaninterviewwith "K", DrFrederick GowlandHopkins, 18Jan. 1901.
Hopkins attributed the remark to "an eminent physiologist", possibly Sir Michael Foster.
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Wellcomethereforepetitioned alltheBMA'sCouncilmembers, stressingtheargument
already used in connection with the WPRL, that the WRCL "as you probably know,
are entirely separate and distinct from my business."175
THE HOME OFFICE DEBATES
Wellcome's application, and the questions it promoted, led the Home Office to
instigate enquiries along three lines: didthe testing ofdiphtheria antitoxins cause pain
in experimental animals? (itwas universally acknowledged that other antitoxin testing
was painful); could a central Testing Station be established and should it be under
direct goverment control?; and was it desirable, and possible, to prosecute the WPRL
or Dowson for infringement of the 1876 Act?
Thane investigated the first ofthese himself, visiting several laboratories to observe
their experimental procedures. The majority, but not unanimous, view was that
diptheria antitoxin testing did not cause pain.176
The second question was referred to both Royal Colleges, the Pharmaceutical
Society, and the Jenner Institute. The problems offinancing a central Testing Station
seemed immense, as none ofthe bodies which supported such a venture was prepared
to be responsible for its cost. The Government was unwilling to establish official
laboratories itself, and Digby felt certain that if another body did not provide such
facilities reasonably quickly, then the registration of the WPRL must be
recommended.177
Thethirdpoint wasclearly related to thefirstquestion and to Dowson's position, as
a licence-holder, under the law. This was the crux ofthe request for the legal opinion
which the Home Secretary addressed to the LawOfficers ofthe Crown. The first draft
of this document stressed, somewhat inelegantly, that
theimportant question arises whether it is not doubtful whether such experiments are
performed for "the purpose ofadvancing knowledge by new discoveries" as, if not,
there appears to be no power to license them, and therefore, however useful, they
175 Wellcome to members ofthe BMA Council, 21 Nov. 1900, WF: Letter Books 1900-1901, S/G/148/1,
pp. 468, 468a; Fawke to Jowett, 1 Nov. 1900, ibid., p. 469; Power to Fawke, 2 Nov. 1900, ibid., p. 470;
Fawke to Power, 3 Nov. 1900, ibid., p. 471. In later years, similar "controversy with respect to the
publication ofpapers" occurred with the PharmaceuticalJournalforsimilar reasons. Wellcome to Dowson,
31 Oct. 1904, WF:HSW Correspondence Personal 6 (1904-1905), p. 188; 11 May 1905, ibid., p. 448; British
Pharmaceutical Conference, Minutes ofExecutive Committee, 1887-1911, 24June 1904, pp. 268-9; 8 Aug.
1904, p. 270; 8 July 1907, p. 318.
176 Thane observed inoculated guinea-pigs at the Conjoint Laboratories and the Jenner Institute, and
questioned several bacteriologists about pain occurring during testing procedures. All notes and reports in
PRO H045/1 1092/B21744/27.
177 Digby to Church, 12 May 1900, suggesting that if no other organization would undertake the
responsibility, then the WPRL should be registered. PROH045/11092/B21744/15. A HO memorandum of
26 July 1900 acknowledges that whilst the Royal Colleges and the Pharmaceutical Society had stressed the
desirability of independent laboratories, they had not offered to perform the task at their own expense,
although "Ifa State Laboratory is not established, there would be no difficulty in finding Laboratories in
London or elsewhere provided with the necessary appliances ... Such laboratories might be used by
authority ofthe Government fortesting these remedies and forissuing certificates at suchcharges as would
cover the expenses incurred". PRO H045/11092/B21744/20.
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cannotbeperformed atalleitherwithorwithoutlicence. Ifthiswereso,itisdifficult to
see how the important processes ofstandardising drugs and antitoxins can be carried
on in any circumstances in which they would be calculated to give pain.'78
The memorandum pointed out that, if the Law Officers decided that testing
experiments were breaches ofthe Act, a difficult administrative situation would arise.
Such work
willcertainly becarried outbythe Firm in France orGermany ifnot done here,-they
are no more painful than numbers that are now being done every day for the
"advancement ofknowledge" and otheradmittedly scientificpurposes, andiftheyare
rendered impossible an important and lucrative branch oftrade will have been driven
from our country, the results of which are most useful in saving life and alleviating
suffering.
The Law Officers considered that testing procedures were to be regarded as
experiments and that the Secretary of State could not make his annual renewal of
Dowson's licence ifhe knew that the law was being broken, although Dowson should
notbeprosecutedforpastmisdemeanours. Aninternalmemorandummaintainedthat
theSecretaryofStatecouldnotrestrictexperimentation atpleasureoroutofsentiment
butcouldonlyrefuseifthe objects oftheresearch wereconsidered to beuseless and/or
ifunfit persons were proposed to perform them: "Ifthis is so, it settles this case, when
once we are satisfiedofthe nature ofthe arrangements made." The Royal College of
Surgeons might perform such operations better, but they could hardly perform them
more painlessly. If the Secretary of State was convinced that the experiments were
useful and necessary and were to be performed by qualified persons, then he should
registerWellcome'spremises. ProfessorThane remarked: "Ifthe requestwere acceded
to, thequestion oftheillegalityoftheproceedings wouldfallthrough in thisparticular
case. Therefore, I think Mr. Wellcome should be asked ifhe has any further statement
to make."179
THE SECOND SUBMISSION: FEBRUARY TO SEPTEMBER 1901
Wellcome had already started the preparation ofa second submission to the Home
Office in the light ofthe comments that Dowson received in the summer of 1900. This
new application, dated 25 February 1901 (a full year after the first) reveals several
differences from the original. The first document's rather flamboyant but abstract
phraseology was now replaced by precise responses to several questions.'80
First, the independence ofthe WPRL from the business company was emphasized,
as was the complementary role of the WRCL in the development of new drugs.
178 Undated draft for the Law Officer's Opinion; Digby to Attorney General, 7 Jan. 1901, sought
clarification ofthe Secretary ofState's powers and responsibilities under the Act, and whether, ifaware of
some illegality, he was obliged to prosecute. PRO H045/11092/B21744/28.
179 Law Officer's Opinion, 14 Feb. 1901; HO Minute by Thane, 2 Mar. 1900; HO memo. 11 Mar. 1901.
PRO H045/1 1092/B21744/29. Thane advised that ifa prosecution ofDowson failed, which he considered
likely, then the 1876 Act would be discredited and "it would probably be necessary to have recourse to
Parliament, with results that no-one can foresee". HO memo 12 June 1901: PRO H045/1 1092/B21744/34.
180 Draft ofa petition from Wellcome to Thomson Ritchie, Secretary ofState at the HO, 25 Feb. 1901,
WF:WPRL Registration. Wellcome to HO, 25 Feb. 1901: PRO H045/1 1092/B21744/30.
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Detailed appendices listed several substances produced in the WCRL and awaiting
physiological testing. Once more, however, thecommercial argumentwas recognized:
at present Germany has the monopoly.... The petitioner, in his capacity as the
principal ofthe firm ofBurroughs Wellcome and Co. is a purchaser ofhundreds of
thousands ofpounds worth ofchemicals which are not, but ought to be, made in this
country.... It may be noted that the value of the British imports of chemicals and
dyestuffs for the year ending 1899 was £5,768,890.1881
Additionally, Wellcome faced the criticisms raised in Dowson's interviews,
declaring that the men he employed were all responsible scientific persons "guided by
the same spirit and by the same aims as actuate all research workers". For a suitable
physiologist he had "approached the highest authority in physiological science at one
of our older Universities,'82 and he maintained that it was particularly invidious to
suggest that a well-trained man
would work in a proper spirit in his University laboratory and in an improper spirit in
any other laboratory, his experiments being "humane" in the former case, and ipso
facto losingthisquality inthelatter shouldithappen to bein anywayconnected with a
commercial firm . . . thedistinctions sometimes suggested between "experimentsmade
for the purposes of trade" and "purely scientific experiments" are devoid of
significance.... The experiments I desire to have conducted in my Physiological
Laboratories would not be "for thepurposes oftrade." They would be made to enable
themembers ofthemedical profession to obtain in this country therapeutic substances
withdefinitelyascertained properties and ofknown strength .... The spirit ofresearch
cannot be confined to institutions of learning.'83
This argument was developed with regard to the contradictory criticisms presented
earlier: if the WPRL was registered the Home Office would have to register inferior
firms, but conversely, if no other companies were registered, then Wellcome might
acquire a valuable monopoly. Wellcome countered
suchdistinctionshoulddependonthefitnessofthelaboratories and ofthosewhowork
in them ... that the possession ofsuch a licence might be ofvalue from a commercial
point ofview implies nothing more than that medical men would probably prefer to
procure therapeutic substances from these firms who voluntarily accept the
responsibility ofstandardising the strength oftheir products .... The initial outlay in
theestablishment ofadequate provision for this kind ofwork, and the annual expense
ofits prosecution, are so great that, taken together with its inherent difficulties and
181 Ibid., Appendix A, pp. 8-11. Chemicals awaiting physiological testing included Jaborandi alkaloids,
natural products such as Strophanus and willow bark, and synthetic compounds including new varieties of
morphine and creosote.
8 Op. cit.,note 180above,p.2.The"highestauthority" wasprobably SirMichael Foster, who hadsigned
the first petition, and whom Dowson had approached in December 1900 on the matter. BW&Co to
Dowson, 5 Dec. 1900, WF:HSW Letter Books 1900-1901, S/G/148/1, p. 607. See also notes 98, 117 and
190.
183 Op. cit., note 180 above, pp. 3-4. A later comment by Lord Moulton (see note 58 above), that
traditional attitudes in medical practice made the acceptance of new ideas particulary difficult, also
emphasized that the concepts of"pure" and "applied" research were vague and artificial; in A. C. Seward
(editor), Science and the nation, Cambridge University Press, 1917, pp. viii-xx.
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responsibilities, such applications are in my opinion likely to be rare. Should no other
application bemade, and thegrantingofsuchlicense bethoughttopracticallyconfera
monopoly with respect to certain therapeutic substances, it appears sufficient to state
that this result could follow only ifother manufacturing chemists failed to incur the
great expense necessary and to furnish adequate guarantees.'84
These lengthy quotations indicate the forcewith whichWellcome nowpresented his
request to the HomeOffice. Some ofthe assertions made in his firstpetition, especially
on the basic need for laboratory testing, were included again in the new submission "I
hold it to be wrong that a drug should receive an extensive trial lasting perhaps for
years on the human subject without previous experiments on animals ... the
administration ofallpowerful ordangerous remedies should firsthaveasound basisin
laboratory experiment."
In the middle ofMarch therewas anencouraging response from the Home Office in
the form ofa request for further details ofexperiments to be performed under licence
and certificates, of who would be employed, and of the arrangements envisaged for
planning and reporting experimental work.185 This was passed to Dowson, Smith,
Chune Fletcher, and Fletcher Moulton, and "It was decided to immediately engage,if
possible, another physiologist, upon the condition that the engagement should not be
ratified unless we secured the license from the Home Office". This person was to
provide the precise details required by the Home Office. Dowson was dispatched to
interview Sir Michael Fosteraboutasuitablecandidate.186Theinitialdraftreplytothe
Home Office was more succinct than those previously submitted. It listed the nature
and number of experiments desired during the first year (e.g. antitoxin work on
typhoid, tetanus and snake-bite; standardization work on digitalis, ergot, and lobelia,
andpurelyexperimentalwork on supra-renal glandextracts)anddescribed thestaffing
arrangements and organization of the different departments of the WPRL.187
Throughout are spaces "to be filled in by the new physiologist" and by the date ofthe
nextdraft, 21 May, "thenewphysiologist" was named asJohn Mellanby ofEmmanuel
College, Cambridge, recommended to Wellcome by both J. N. Langley and F. G.
Hopkins.188 This final version listed not only the number ofexperiments but also the
1840p. cit., note 180 above, pp. 2-3. D. H. Aldcroft argued that the coveted goal of the Victorian
entrepreneur was to become one of the landed gentry, but Wellcome's aspirations were clearly different.
'The entrepreneur and the British economy 1870-1914', Econ. Hist. Rev., 1964, 17: 113-4.
185 HO memo 11 Mar. 1901, PRO H045/11092/B21744/29; HO to Wellcome, 21 Mar. 1901, PRO
HO156/14 p. 545.
186 BW&Co to Wellcome, 4 Apr. 1901, WF:HSW Letter Books c. 1900, S/G/148/0, p. 550, memo. 456.
Dowson consulted Brodie (see note 168 above), Starling, Sir John Burdon Sanderson and Schafer (see note
117 above).
187 Draft, Wellcome to HO, 2 Apr. 1901, WF:WPRL Registration. The letter cited in note 182 above
emphasized the importance of reducing the number of experiments in the recognition that the most
important goal was registration.
'88 BW&Co to Wellcome, 3 May 1901, WF:HSW Letter Books c. 1900, S/G/148/0, p. 694. Mellanby, a
"young man ofgreat attainment and of a brilliant future", was employed because BW&Co could not find
the candidate they wanted. BW&Co to Wellcome, 17 May 1901, ibid., p. 809, memo. 560. Mellanby's initial
contract was conditional upon the registration of the WPRL: BW&Co to Mellanby, 17 May 1901, ibid.,
p. 817.
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certificates that would be required, as, for example, in the presentation of the
proposed antitoxin work:-
(a) The injection of cultures of microbes into rodents,-chiefly guinea-pigs would
be used-
about 50 experiments with typhoid cultures, certificate A
about 50 experiments with tetanus cultures, certificate A
about 50 experiments with snake venom cultures, certificate A"89
"It has undoubtedly the right swing about it now, which I feel we owe mainly to the
kindness of Sir Michael Foster."190 With this second submission was a formal
application form to the Home Office, which Dowson had finally been advised to
include.191
The file was once again passed to Professor Thane, who wrote a lengthy minute,
weighing up the argumants for and against the registration ofthe WPRL. He made it
clear that he considered it unreasonable to prevent a manufacturer from testing in
guinea-pigs the serum he was allowed to raise in horses; and he emphasized the
practical importance ofsuch work, the eminent support that Wellcome had obtained,
and the considerable development that was to be expected in such standardization
work. These arguments were followed closely by Digby, who came "somewhat
reluctantly to the conclusion that the application to register Messrs. Burroughs &
Wellcome's laboratories must be granted. I say 'reluctantly' because I think that
besides the outcry which will no doubt be raised by the Anti-vivisectionists, the Home
Office will be taking a newdeparture, which will lead to somedifficulties, butwhich in
my view is inevitable."192 Thane was asked to visit the laboratories once more.
Dowson was recalled from his annual holiday to Brockwell Hall and J. C. Smith
visited the laboratories to ensure a special "clean-up", prior to the meeting. Thane
saw nothing that required him to modify his previous inspection report and
recommended registration.'93
On 6 September 1901, a letter arrived at the Company Headquarters from the
Home Office, announcing that the WPRL had been registered under the 1876 Act.
Copies were immediately dispatched to Smith, Dowson, and Chune Fletcher, and to
189 Wellcome to HO, 21 May 1901, ibid., pp. 834-6.
190 Telegram, Dowson to BW&Co, 4 Apr. 1901; Dowson to BW&Co, 21 May 1901, both in WF:WPRL
Registration; BW&Co to Moulton, 10 Apr. 1901, WF:HSW Letter Books c. 1901, S/G/148/0, p. 556. "The
wording and arrangement of the list ofproposed wprk for the first year was written out by Sir Michael
himself": BW&Co to Wellcome, 12 Apr. 1901, ibid., p. 565, memo. 462.
191 Dowson toBW&Co, 21 May 1901,quoted inthelettercitedin note 189above; BW&Co toDowson, 22
May 1901, ibid., p. 839. The HO agreed that the proposals were "of [a]justifiable nature" and that after
Thane had inspected the WPRL again, registration was likely. HO memo, 27 May 1901. PRO
H045/1 1092/B21744/32.
192 HOMinutebyThane, 12June 1901; notebyDigby, 15June 1901. Both in PROH045/1 1092/B21744/
34.
193 Telegram, BW&Co to Dowson, 14 Aug. 1901, WF:HSW Letter Books June to Nov. 1901, S/G/148/6,
p. 281; BW&Co to Dowson, 14 Aug. 1901, ibid., p. 282; BW&Co to Thane, 15 Aug. 1901, ibid.,
p. 280. HO memo by Thane, 20 Aug. 1901, PRO H045/1 1092/B21744/34. See also note 105 above. HO
officials decided not to perform the "rather awkward task" of informing the Royal Colleges or the
Pharmaceutical Society of their decision.
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Henry Wellcome in Switzerland,194 who was "gratified to learn that my physiological
research laboratories have been registered as a place at which experiments on living
animals may be performed."195 In the same week a press report from the British
Pharmaceutical Conference commented appreciatively on the standardization work
undertaken by Parke Davis and Company in America. It concluded that although
British firms were often reluctant to accept the financial responsibility ofsuch work,
the "Anti-Vivisection Act" also prohibited them from using such methods.196 The
registration of the WPRL was about to change that situation.
THE WPRL AFTER REGISTRATION197
Once registration was granted, the Company decided to extend their diagnostic
services, and sought "a really able man".198 W. V. Shaw, a pathologist at St Mary's
Hospital, London, was appointed at the beginning of January 1902, when John
Mellanby, whose previous contract was subject to Home Office registration, was
offered a permanent position.199 These contracts raised several problems because of
their "commercial" character with regard toconditions ofservice, holiday allowances
and, more importantly, restrictions upon publication.
It is understood that you are to treat as strictly confidential, and respect as my
property, all my manufacturing processes, formulae, apparatus etc. and all
improvements therein, and also anyinventions or newdiscoveries which maybemade
byyouoranyoneelseinmyemployment; ontheunderstanding that I shall notextract
from you with respect to any discovery a confidence which is contrary to the ethics of
your profession.
Itisalsounderstoodthatbeforepublishinganycommunications uponphysiological
matters or upon any work connected with the Laboratories you are first to submit
same to and obtain the approval of the Director.
The two clausesjust written refer to work done at any time either in or out ofthe
Laboratories.200
Theproblemofofferingsuchdocuments toscientificstaffhadbeenraisedbyChune
Fletcher, whocomplainedthatthewordingwastotallyunsuitable. Hemaintainedthat
the annual holiday allowance ofthree weeks was insufficient for a good professional
194 HO to Wellcome, 5 Sept. 1901; PRO HO156/14 p. 768, also advising that, as the Secretary of State
believed antitoxin testing to come under the 1876 Act, licensees would require Certificates. Dowson to
BW&Co, 6 Sept. 1901; BW&Co to Wellcome, 6 Sept. 1901. Both in WF:WPRL Registration. Anti-
vivisectionists were informed of the registration; e.g. HO to International Anti-Vivisection Council, 26
Sept. 1901. PRO HO156/14 p. 784.
Wellcome to HO, 27 Sept. 1901, WF:HSW Letter Books June to Nov. 1901, S/G/148/6, p. 492.
196 Chem. & Drug., 1901, 59: 412.
197 After registration, security at the WPRL was closely reviewed: BW&Co to Wellcome, 19 Oct. 1901,
WF:HSW Letter Books June to Nov. 1901, S/G/148/6, p. 672 memo. 817. Registration also brought the
WPRL under the protection ofthe law, when, forexample, stolen cats were mistakenly bought: see Chem.
& Drug., 1905, 66: 348, and several letters in WF: Letter Book HSW & BW&Co 1904-1906.
198 BW&CotoPlimmer, Burdon-Sanderson, andRitchie, forreferencesforShaw,20Dec. 1901,WF:HSW
Letter Books Nov. 1901-Feb. 1902, S/G/148/7, pp. 285-7.
199 BW&Co toShaw, 12 Dec. 1901, invitinghim foraninterview, ibid., p. 223. There is no indication that
other candidates were considered, or had even applied. BW&Co to Dowson, 20 Dec. 1901, ibid., p. 284;
Wellcome toShaw, 1 Jan. 1902,ibid., p.440; Wellcome toMellanby, 1 Jan. 1902,ibid., p.441. Seealsonote
188 above.
200E.g.,WellcometoMellanby,ibid.; MellanbytoWellcome, 15Jan. 1902,WF:E2DW,'WPRL1895-1922'.
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man, and that thiswasexactly the kind ofrestriction that wouldprevent such aperson
joining, or remaining in, the laboratories.201 He became even blunter about the
necessity of Company policy not upsetting work at the WPRL
so that they can make a thoroughly good start now that they are registered, every
consistent concession should be made. The trouble and anxiety which we have had to
securemen for these laboratories, has beenexceedingly great, and onemust notforget
that the proportion of men sufficiently broad-minded to be associated with your
laboratories is very small. With Dr. Dowson, Dr. Shaw and Mr. Mellanby we think
there isagreat opportunity forcreditable work to bedone atthelaboratories, butthey
must have every encouragement and stimulant possible.202
In addition to serum production and diagnostic work, registration under the 1876
Act permitted Wellcome to employ physiologists and pharmacologists to prosecute
"pure" research, and his most famous recruit was undoubtedly Henry Dale,203 who
joined theWPRL in 1904. However, prejudices and misconceptions still prevailed and
hewaswarned "Ishouldbesellingmyscientificbirthright ... foramessofcommercial
pottage", although "I never had serious or lasting reason to regret the change which I
had made".204 Indeed, Wellcome's request to E. H. Starling for a reference for Dale
again emphasized the laboratories' independence from the commercial organization,
and that he was looking for
amanwhoiscapableofbroad anddeepthinking, whohasfertilityofmind, originality
andalertness, andpatientpersistence; aman who willconcentrate hiswhole mind and
energies on this work. I want the work in these laboratories to be done on the highest
scientific lines and with such a thoroughnessand precision that it will stand the test of
time and the keenest criticism.205
Dale's arrival at the WPRL in 1904, and promotion to Director in 1906,206
detieZ-nined very clearly the scientific direction ofthe research work undertaken there.
Over 50 years later, he remarked upon "the absence, till then, ofany realjustification
for the title 'Physiological Research Laboratories'. This was the name which had been
given to them by Mr. Wellcome when he founded them ... and it was obviously
represented hishopes andaspirations."207 Awide rangeofhigh-quality research work
201 BW&Co to Wellcome, 28 Dec. 1901, ibid., p. 329, memo. 1207.
202 BW&Co to Wellcome, 31 Jan. 1902, WF:HSW Letter Books 1900-1901, S/G/148/6, p. 735, memo.
1461; 'Still growing', Chem. & Drug., 1902, 61: 768.
203 Dale worked at the WPRL until 1914, when hejoined the new Medical Research Committee (now
Council). Some ofhiswork at the WPRL led to hisreceipt,jointly with Otto Loewi, ofthe 1936 Nobel Prize
in Physiology or Medicine. W. S. Feldberg, 'Henry Hallett Dale, 1875-1968', Biog. Mems FRS Lond.,
1970, 16: 77-174; see also H. H. Dale, Adventures in physiology, London, The Wellcome Trust, 1965.
204 H. H. Dale, 'Autobiographical sketch', Perspect. Biol. & Med., 1958, 1: 125-37.
205 Wellcome to Starling, 2 June 1904, WF:HSW Letter Book Personal 5, 1903-1904, S/G/148/6, p. 399.
206 Dowson resigned when the U.S. PublicHealth Service refused to import BW&Co's antitoxins because
ofcontamination, albeit with a non-pathogenic organism. In a scenario reminiscent ofBokenham's story,
Dowson rejected their findings. Wellcome referred to external experts and when they confirmed the
contamination Dowson resigned, leaving Dale as the only person available to supervise serum production.
Dale to Fowler, 20 June 1960; Fowler to Dale, 28 June 1960. Both letters RS: 93HD 65.5, Brockwell Hall,
1952-1967. See also Feldberg, op. cit., note 203 above, pp. 99-100.
207 AddressofSirHenryDaleattheopeningofnewWellcomelaboratories, 1 May 1959,WF/95.Theyhad
not, of course, been known as the Physiological Laboratories from their foundation.
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was performed at the WPRL after the granting ofHome Office Registration.208 One
indication ofthe calibre ofscientists recruited to the WPRL at Brockwell Hall is the
number ofthem that were subsequently elected to Fellowship ofthe Royal Society.209
It is pertinent to consider two further questions: did the Home Office's registration
ofthe WPRL open the flood-gates to numerous "commercial" applications? and did
the registration ofthe WPRL itselfgreatly increase the total number ofexperiments
performed under the 1876 Act?
PHARMACEUTICAL COMPANIES AND HOME OFFICE REGISTRATION
Difficulties with the Home Office were not entirely resolved with the granting of
registration: in January 1902, Shaw applied for a licence and certificates to carry out
cancer research.210 Not only was he identified in Home Office records as "a new
Burroughs&Wellcomeman" butcontinuing doubtswereexpressedabouttheworkof
theWPRL: "ThisraisesthequestionwhethertheBurroughs&Wellcome Laboratories
are to be used for general original research and diagnosis, or merely for the processes
involving experiments under the Act, which are necessary for Messrs. B.&W.'s
business".211
Inevitably, ProfessorThane was asked for his opinion, and he produced a five-page
report on the practicability oflimiting work at the WPRL. This emphasized the word
"research" in the title of the laboratories and Wellcome's intention, implicit in his
application, ofprosecuting research not directly associated with serum production or
drug standardization. Thane stressed his belief that an application merely for such
procedures would have been refused, and maintained that
There is no doubt that Mr. W. desires to get research work done in, and scientific
paperspublished from,hisPhysiological ResearchLaboratories,justasisthecasewith
his Chemical Research Laboratories.
In the eyes of many persons it will be a merit that scientific work is done in the
laboratory in addition to trade work.
208 After registration until the WPRL moved in 1922. over 125 papers were published on physiological,
pharmacological and bacteriological topics. A briefreview may be found in J. Vane, 'The research heritage
of Henry Wellcome', Pharmaceut. Hist. 1980, 10: 2-8. See also Kellaway, op. cit., note 19 above; and
MacDonald, op. cit., note 5 above, pp. 71-89.
209 Details taken from StaffRecord Book 1879-1902, WF:P2 and the typescript 'History ofthe Firm file',
op. cit., note 19 above. Dale (op. cit., note 203 above), Glenny (op. cit., note 92 above) and J. W. Trevan
(1887-1956) were all honoured whilst employed by Wellcome, although Dale's election coincided with his
resignation. Dale to Wellcome, 1 May 1914, RS 93HD 64.2, Personal File Correspondence 1904-1948.
Later Fellows who were early WPRL employees include John Mellanby (1878-1939); A. J. Ewins (op. cit.,
note 94 above); G. Barger (1878-1939); Edward Mellanby (1884-1955); P. P. Laidlaw (1881-1940);
H. King (1887-1956); J. H. Burn (1892-1981); and Percival Hartley (1881-1957). Details oftheir careers,
including time at the WPRL, may be found in the Obituary Notices or Biographical Memoirs series ofthe
Royal Society. Dale was later involved in Wellcome himself being created FRS: Elliott to Dale, 25 Nov.
1931, RS 93HD T. R. Elliott 36.4.4.; Dale to Elliott, 26 Nov. 1931, ibid., 36.4.5.
210 Dowson believed thatwork oncancerwouldbringcredit totheWPRL: BW&Co toWellcome, 28 Dec.
1901, WF:HSW Letter Books Nov. 1901 to Feb. 1902, S/G/148/7, p. 327, memo. 1203. Applications by
W. V. Shaw, for licence and certificates A and B. 31 Jan. 1902, PRO H0144/640/B37553.
211 Memo, 25 Feb. 1902, PRO H0144/640/B37553.
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He concluded that work by a licence holder on registered premises could only be
limited byrefusingapplications foradditionalcertificates, andthattheproposedwork
was perfectly proper.
I looked upon it as certain, when registration was granted, that the thing would
develop, but one could not see exactly on what lines. I consider the certificates
submitted by Mr. W. Vernon Shaw to be quiteconsistent with the objects set forth by
Mr. Wellcome in his application for registration.212
Home Office files contain additional correspondence about Shaw's certificates, his
subsequent work and the resultant publication, but afterThane's memorandum there
appears to have been no further question about the research role of the WPRL.
A fear which had been consistently expressed during the period of Wellcome's
application was, thatifitweresuccessful, itwouldcreateadangerousprecedentforthe
registration ofother commercial premises. However it was over four years before the
Home Office next received an application from a pharmaceutical company. In
November 1905, Brady & Martin, from Newcastle-upon-Tyne, applied not only for
registration but also for a licence for Dr William Martin. Their submission has a
familiarring: "Thegrounds upon onwhichtheapplication ismadearethatduringlate
yearstherehasbeenaneverincreasingdemandformedicineswhichhavebeencertified
to come up to a required standard". After listing the work in this direction ofParke
Davis and Company, Mulford, and Sharpe and Dohme in America, it concludes
"Finally, MessrsBurroughs, WellcomeandCo. havehadalicense[sic]grantedtothem
for making experiments on animals in this country."213
Although Brady & Martin's staffdid not even include an Home Office licensee,214
unlike Wellcome's when he applied, the Home Office did accept the precedent ofthe
WPRL registration. A note in their files by Sir James Russell, the Inspector for the
North ofEngland and Scotland, contains some intriguing remarks in the light ofthe
problems that had faced Henry Wellcome, "Brady & Martin Limited is a purely
English company of the highest standing. The Directors are scientific men who are
much respected andwhodonotputmeremoneyconsiderations inthe firstplaceinthe
conductoftheirbusiness". Aftercommenting thatoneoftheprincipals, N. H. Martin,
wasalocalmagistrate andknowntohimpersonally, Russellcontinued: "Theprinciple
of registration has been settled already by the grant ofregistration to Burroughs &
Welcome [sic], a firm ofAmerican origin." Russell's recommendation was annotated
by the Chief Inspector, Thane, "Wellcome's laboratories having been registered it is
not possible to refuse the demand of another manufacturing chemist who makes
satisfactory arrangements as toplace&person."215 Afurthermemorandum reiterates
212 Thane memo, 8 March 1902, PRO H0144/644/B37553/1.
213 Martin to HO, 8 Nov. 1905, PRO H0144/738/114089/2.
214 Several incomplete applications had been submitted during the time ofWellcome's own petition, e.g.
registration was requested for the Physiological Laboratory, University College, Bristol. Thane admitted
"There is no special animal house at present", but recommended registration, 17 Oct. 1900, PRO
H0144/970/B32790/1.
215 HOMinutebySir James Russell, 15 Nov. 1905; HO MinutebyThane, 17 Nov. 1905,quoting Russell's
letter, PRO H0144/738/114089/2.
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the importance ofprecedent,216 the very argument thatcaused so much concern at the
time ofWellcome's original petition: "The principle having once been established in
that case [i.e., that ofthe WPRL] it would be difficult to refuse a similar privilege to a
purely English firm like Messrs Brady & Martin who seem to be of the highest
standing"..217 Thefinal entryin the HomeOffice filereads "There seems no doubt that
if one place is licensed, another ought to be if sufficiently equipped to do the work
satisfactorily ... Ifthe toxin is notmadein England, themanufacturers will only have
togotoGermany. Thedemandexistsandmustbesatisfiedsomehow."218 Withinthree
weeks of submitting their request, the premises of Brady & Martin were registered
underthe 1876Act, andDrWilliam Martinwasgranted apersonal licence. Thereisno
evidence that the Home Office consulted other bodies about the application, or that
there was any serious debate over the granting of the request.219
Over ten years later, in 1916, the laboratories ofthe next pharmaceutical company,
May & Baker, in Wandsworth, South London, were registered.220 By this time there
had been amarked increase in the number ofregistered places, mainly due to wartime
contingencies. (In 1916, 22 new places were added to the Home Office Register,
bringing the total to over 160, compared with 96 in 1913). 1919 saw the registration of
premises belonging to Nathan and Company in London, and Lever Brothers in Port
Sunlight; and the following year five more commercial premises achieved registration
aswell astwomoreWellcomepremises: theWellcome BureauofScientific Research at
Endsleigh Gardens, London and theirsubsidiary Field Laboratories at Ripley, the site
oftheWellcome Entomological Laboratories.221 Bythistimethereseemstohavebeen
no debate at all about the suitability of "commercial" companies for the privilege of
registration, and such applications were routinely considered along with those from
hospitals and university departments.
An important complementary issue is the impact that the registration of the
WPRL had on the Annual Returns ofExperiments. There had been a steady increase
in the numbers of licensees, registered places and experiments performed from 1893
until 1901, and this trend continued from 1902 onwards.222 A summary of the
relevant figures is shown in table 2.
There was an increase in all categories between 1901 and 1902, partly due to the
"accounting" procedures adopted by the Home Office, as licensees submitted their
216 Precedence frequently determined policy. When the first Municipal Laboratory was registered in 1899
for example, it had "raised a general question", and was subsequently used tojustify similar applications,
HO Report by Russell, 5 Mar. 1900, PRO H0144/451/B.30824A/l.
217 HO memo, Nov. 1905, PRO H0144/738/114089/2. No hint of this chauvinist attitude emerged
during Wellcome's application.
218 HO memo, 21 Nov. 1905, PRO H0144/738/114089/2.
219 Forthisthree-weekperiod, noevidenceofrelevantcorrespondence in HOrecords, Council Minutesof
the RCS orcomment in the Press has been located, in striking contrast to the discussions that accompanied
Wellcome's application.
220 HO Returns, 1916. The Runcom Research Laboratories, started by C. S. Sherrington and Liverpool
colleagues, provided facilities for the study ofcomparative pathology and for the raising ofantitoxins and
vaccines, and were associated with the Evans Medical Company. They were registered with the Home
Office in 1910, but their role within the company has not been ascertained. The story of Evans Medical
1809-1959, Evans Medical Supplies Limited, Liverpool, n.d.; Nature, 1937, 140: 676.
221 HO Returns, 1917.
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Table 2: Summary of the Returns of Experiments, 1900-1903
Experiments Certificate
Licensees Total under not under 'A'
Total Active places anaesthetics experiments
1900 247 184 47 1885 8954 8825
1901 257 201 52 2049 9596 9504
1902 319 207 59 2130 12,776 12,630
1903 347 250 72 2171 16,913 16,712
Annual Returns at the end ofFebruary 1903 instead ofDecember 1902, to coincide
with the licence renewal date. Thus for the 1902 returns, the figures refer to a period
of 14 months (January 1902 to February 1903) compared with the figures for the
previous 12-month period (January to December 1901). Even so, a crude analysis of
"experimentspermonth"-792in 1901,902in 1902-indicatesaveryrealincrease in
the number ofexperiments. The increase in the number oflicensees, 62 during this
year, was specifically referred to in the Chief Inspector's report to the Secretary of
State, where it was explained by the extended time period ofanalysis. Although this
may be true, it does not account for the increase in the number of experiments
performed. The Home Office was concerned tojustify the increase in animal usage,
particularly the large number ofexperiments performed without anaesthetic, and to
relate these to public utility. The Inspector emphasized that, of the 12,776 such
experiments in 1902, overhalfwereundertaken byjust 23 licensees testing antitoxins
orperforming inoculation experiments on behalfofsuch official bodies as the Local
Government Board, the House of Commons Ventilation Committee, the Royal
Commission on Tuberculosis, the Board of Agriculture, and several County
Councils and Municipal Corporations. Much ofthe work involved testing milk, the
examination of hair for contamination with anthrax, or the testing of sewage
effluent.
Wastheregistration oftheWPRLasignificant factorinthisincrease?223 When the
WPRL was registered, Dowson was the only licensee there, and his licence was also
available at the New Museums site in Cambridge. In December 1901, John
Mellanby's licence became available for the WPRL, in addition to the Cambridge
site. Their returns for 1901 were both modest: Mellanby performed 17 licence-only
experiments (out of the total of 1,176 such experiments) and Dowson made 127
experiments under Certificate A (out of 9,504 'A' returns). It is not possible to
ascertainwheretheworkwasdone, althoughmostofitwasundoubtedly doneforthe
WPRL. In 1902therewere three licensees at theWPRL, Dowson and Mellanby with
theirdual availability, and W. V. Shawwith availability only at theWPRL. Again, it
is not possible to tell precisely where the work was performed, but it is unlikely that
once the WPRL were registered it was either necessary or desirable foremployees to
work elsewhere. These three men performed 2,366 experiments, out of the annual
222 See also French, op. cit., note 3 above, pp. 392-405.
223 Details of experiments performed by licensees at the WPRL are taken from HO Returns for the
relevant years.
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total of 14,906, and thus contributed substantially to the increased returns for 1902.
When the returns under A certificates are analysed separately, it can be seen from
table 2 that the increase in such returns between 1901 and 1902 is 3,216, and ofthese
2,261 were experiments reported from the WPRL. In 1908, eleven licences were
available at the WPRL, and they performed at least 5,266 experiments out ofa total
of88,634.224 Thus in those six years the Wellcome returns had doubled, although the
total returns had increased by almost a factor of six. The registration of the WPRL
and similar "commercial" laboratories did not, therefore, increase the animal
experimentation figures as significantly as had been feared during Wellcome's
application for registration.
CONCLUSION
In 1921 Burroughs Wellcome and Co.'s lease on Brockwell Park was running out,
with no possibility of renewal.225 Eventually, new property was acquired in
Beckenham, at Langley Court. Although there was some local opposition to the
enterprise, strong offical support for the laboratories and their work was
forthcoming.226 Henry Wellcome's sustained but ultimately successful application
had convinced the Home Office and much ofthe medical profession that research on
"commercial" premises was not necessarily tainted or substandard. The new premises
were registered by the Home Office without demur,227 and Wellcome's Physiological
Research Laboratories subsequently provided facilities and opportunities that
completely justified the optimism expressed by Henry Dale in a letter to Henry
Wellcome in 1906, ". . . I hope some day to see the aid of commerce by physiology
recognised as an important & desirable brand ofmedical science in England, & to see
your laboratories recognised as the pioneer institution."228
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